Fungal production system

Information

  • Patent Grant
  • 9175296
  • Patent Number
    9,175,296
  • Date Filed
    Tuesday, March 16, 2010
    14 years ago
  • Date Issued
    Tuesday, November 3, 2015
    8 years ago
Abstract
The present invention provides a new fungal production system comprising a fungal host strain of Chrysosporium lucknowense wherein the endogenous cellulase secretion is less than 20% of the endogenous cellulase secretion of Chrysosporium lucknowense strain UV 18-25. Preferably, also the secretion of endogenous protease, endogenous β-glucanase and endogenous cellobiohydrolase is less than 20% of the secretion of Chrysosporium lucknowense strain UV 18-25. Furthermore, fungal host strains are provided wherein several genes have been disrupted. According to another aspect of the invention a method for homologous and/or heterologous production of a pure protein with a purity of higher than 75%, comprising expressing a gene encoding said protein in the strains according to the invention have been described. Furthermore, a method for production of artificial protein mixes comprising expressing a gene encoding each of said proteins in a strain according to the invention have been disclosed. Finally a method for simplified screening of strains functionally expressing a desired enzyme by application of said strains have been provided.
Description

This application is the U.S. national phase of International Application No. PCT/NL2010/000045 filed 16 Mar. 2010, which designated the U.S., and claims priority to EP Application No. 09003750 filed 16 Mar. 2009, the entire contents of which is hereby incorporated by reference.


The present invention relates to a fungal host strain of Chrysosporium lucknowense. The invention relates furthermore to a method for homologous and/or heterologous production of a pure protein with a purity of higher than 75%, to a method for production of artificial protein mixes and to a method for simplified screening of strains functionally expressing a desired enzyme. The invention relates furthermore to an isolated promoter sequence suitable for the transcriptional control of gene expression in Chrysosporium lucknowense and to a method for isolating a fungal host strain of Chrysosporium lucknowense wherein the protease secretion is less than 20% of the protease secretion of Chrysosporium lucknowense strain UV 18-25.


Fungi have been proven to be excellent hosts for the production of a variety of enzymes. Strains like Aspergillus, Trichoderma, Penicillium and recently the fungus Chrysosporium lucknowense C1, have been applied in the industrial production of a wide range of enzymes. Super-producing strains have been developed that secrete up to 100 g/L or more protein in the fermentation broth (see for instance in Hans Visser et al., Abstracts, J. of Biotechnology, S211-S241 (2007). The large protein-secreting capacity of these fungi make it preferred hosts for the targeted production of specific enzymes or enzyme mixes. However, typically, these hosts secrete a mix of many different enzymes, making the crude protein product undefined and yielding, besides the desired enzyme activity, a range of non-relevant or even contra-productive activities. This also holds true for the use of such fungal hosts for production of specific enzyme activities by over-expression of selected genes via genetic modification approaches. Also in these cases the target enzyme will only constitute a minor part of the total secreted protein.


A microbial production system able to secrete high amounts of a specific enzyme without the presence of high levels of other proteins would be highly desirable. It would enable simplified screening of hosts functionally expressing a desired enzyme. It would enable production of relatively pure enzyme. It would also enable simplified large scale purification of the desired enzyme. These advantages would greatly contribute to e.g. easy generation of artificial enzyme mixes tailored for different applications, e.g. plant biomass hydrolysis (biofuels and chemicals), textile finishing, applications in paper and pulp industry.


The relatively clean production of specific extracellular enzymes to high levels by micro-organisms that do not intrinsically secrete high levels of protein would be a non-preferred approach. The limited enzyme secreting capacity of such organisms would prevent high level production of the enzyme of interest.


The object of the present invention comprises the isolation of mutants of a fungal strain with high secretion capacity that unexpectedly no longer produce high levels of many non-desired proteins, while maintaining good growth characteristics, and amenability to genetic modification. These mutant strains were should be able to function as a host for high level production of specific enzymes.


In order to achieve the intended object of the invention the invention provides a fungal host strain of Chrysosporium lucknowense wherein the endogenous cellulase secretion is less than 20% of the endogenous cellulase secretion of Chrysosporium lucknowense strain UV 18-25, preferably less than 15%, more preferably less than 10%, specifically less than 5%, more specifally less than 2%, more specifically less than 1%, most specifically less than 0.5%, or less than 0.1%. The strain Chrysosporium lucknowense strain UV 18-25 has been described in the international patent application WO 0020555. Preferably, the secretion of one or more of the group consisting of endogenous protease, endogenous β-glucanase and endogenous cellobiohydrolase of the fungal host strain according to the invention is less than 20%, more preferably less than 15%, most preferably less than 10%, especially less than 5%, more especially less than 1% most especially less than 0.5% or 0.1% of the secretion of endogenous protease, endogenous β-glucanase and endogenous cellobiohydrolase respectively of the Chrysosporium lucknowense strain UV 18-25. All percentages mentioned apply to the secretion of protease, β-glucanase and cellobiohydrolase independently.


Preferably the strains according to the present invention are further characterized in that secretion of endogenous cellobiohydrolase 1 (Cbh1) is absent. Most preferably the strain according to the present invention is strain W1L, deposited at the Centraal Bureau Schimmelcultures (CBS) under accession nr 122189 or W1L#100.1 deposited at the CBS under accession number 122190.


More preferably from the strains according to the present invention the gene encoding endochitinase 1 (chit) has been disrupted. Most preferably, one or more genes selected from the group consisting of those encoding alkaline protease 1 (alp1), alkaline protease 2 (alp2), proteinase A (pep4), glucoamylase (Gla1), exo-chitinase (Chi2) and laminarinase (Lam1) have been disrupted. Especially, the strains according to the invention are W1L#100.lΔalp1Δpyr5 or W1L#100.lΔalp1Δchi1Δpyr5.


The invention also relates to a method for homologous and/or heterologous production of a pure protein with a purity of higher than 75%, preferably of higher than 80%, more preferably of higher than 85, 90 or 95%, comprising expressing a gene encoding said protein in a strain according to the invention. Especially the invention provides a method for production of artificial protein mixes comprising expressing genes encoding each of said proteins of the mix in a strain according to the invention. In this way protein mixes may be prepared for different applications, e.g. plant biomass hydrolysis (bio fuels and chemicals), textile finishing, applications in paper and pulp industry). Furthermore the invention provides a method for simplified screening of strains functionally expressing a desired enzyme by application of strains according to the present invention.


According to another aspect of the invention an isolated promoter sequence is provided suitable for the transcriptional control of gene expression in Chrysosporium lucknowense, selected from the group consisting of

    • a. the chi1 (0.8) promoter comprising the nucleotide sequence of SEQ ID NO 25,
    • b. the chi1 (1.8) promoter comprising the nucleotide sequence of SEQ ID NO 26,
    • c. the hex1 promoter comprising the nucleotide sequence of SEQ ID NO 27,
    • d. the xyl6 promoter comprising the nucleotide sequence of SEQ ID NO 28, and
    • e. the gla promoter comprising the nucleotide sequence of SEQ ID NO 29 or a transcriptionally active part thereof.


Also a chimeric gene comprising said promoter sequence and a host comprising said promoter and chimeric gene are provided by the present invention.


Finally a method for isolating a fungal host strain of Chrysosporium lucknowense wherein the cellulase and protease secretion is less than 20% of the cellulase respectively protease secretion of Chrysosporium lucknowense strain UV 18-25, comprising the steps of

    • (i) plating Chrysosporium lucknowense on acid swollen cellulose (ASC) plates,
    • (ii) selecting at least one colony showing a reduced cellulose clearing zone,
    • (iii) plating the strain selected in step (ii) on skim milk plates, and
    • (iv) selecting at least one colony showing a reduced protein degradation halo,


      has been provided. Preferably this method further comprises the steps of mutagenesis prior to steps (i) and/or (iii).


If in this patent application patent hosts are defined by comparing the level of production of various enzymes with the Chrysosporium lucknowense strain UV 18-25 then of course the production of one and the same enzyme in the host has to be compared with that in the Chrysosporium lucknowense strain UV 18-25.


The proteins mentioned in this patent application as for instance protease, β-glucanase, cellobiohydrolase, proteinase A, β-glucanase, exo-chitinase and laminarinase have been defined as described in WO 2009/0918537 in the name of Dyadic International INC.


To emphasize the advantages provided by the present invention: it relates to the isolation of novel fungal hosts that have lost their intrinsic capability to secrete high levels variety of background proteins, while retaining the ability to secrete high levels of only few enzyme activities. The invention also relates to the use of these hosts to produce specific enzymes at high levels without co-production of high levels of non-specific proteins. In addition the invention relates to the generation of defined artificial enzyme mixes tailored for different applications.


The invention will now be elucidated by the following non-limiting examples.





Legends to the figures mentioned:



FIG. 1: Medium samples of UVI8-25, W1L wildtype, W1D wildtype and the protease mutants W1L#100.1, W1D #50.g and W1D #100.b on SDS-PAGE. These strains were cultivated in medium #1 (low density medium with cellulose) for 282 hours except for lane 8 which is a sample in medium #2 (high density). The medium sample in lane 1 was 2 times diluted and the medium sample in lane 8 was 4 times diluted.



FIG. 2: Shake flask culture medium samples of C1 strain W1L#100.1 and derivatives. Lane 1, W1L#100.1; lane 2, W1L#100.1Δchi1; lane 3, W1L#100.1Δalp1; lane 4, W1L#100.1Δalp1Δchi1.



FIG. 3: Cosmid cloning vector pAopyrGcosarp1.



FIG. 4: Plasmid pCHI4.8. The plasmid, which was isolated from E. coli clone #5 is shown. This plasmid was used in the construction of the white strain gene expression vectors.



FIG. 5: Over-expression of chi1 via the introduction of extra chi1 gene copies in W1L#100.1. Lane 1, W1L#100.1 wild type strain (control); lane 3, W1L#100.1[chi+/pyr5]#3; lane 4, W1L#100.1[chi+/pyr5]#9; lane 5, W1L#100.1[chi+/pyr5]#17.



FIG. 6: Plasmid Pcbh1-glaA(II)-Tcbh1. This plasmid was used in the construction of the white strain gene expression vectors.



FIG. 7: The pPchi1(1.8)-Tcbh1 NotI gene expression vector.



FIG. 8: A schematic map of the pCRS-pPchi1(1.8)-Tcbh1 gene expression vector.



FIG. 9: SDS-PAGE analysis of culture supernatant samples of W1L#100.L Δalp1Δpyr5 (B2), and CL10518-expressing transformant strains of W1L#100.L Δalp1Δpyr5 (B3, B4). The arrow indicates the CL10518 position.



FIG. 10: SDS-PAGE analysis of culture supernatant samples of W1L#100.L Δalp1Δpyr5 (D1), and of cbh2-expressing transformant strains of W1L#100.L Δalp1Δpyr5 (D3-D5). The arrow indicates the CBH2 position.



FIG. 11: SDS-PAGE analysis of culture supernatant samples of W1L#100.L Δalp1Δchi1Δpyr5 transformed with pyr5 only (C), and of pgx-expressing transformant strains of W1L#100.L Δalp1Δchi1Δpyr5 (1, 2).



FIG. 12: SDS-PAGE analysis of culture supernatant samples of W1L#100.L Δalp1Δchi1Δpyr5 transformed with xyl1 (31, 34) and with xyl1Δcbd. The arrows indicate the protein bands representing the respective xylanase variants.



FIG. 13: SDS-PAGE analysis of culture supernatant samples of W1L#100.L Δalp1Δchi1Δpyr5 transformed with med with selection marker only (71) and with abn2 (68-70), M, marker.



FIG. 14: Analysis of chi1 transformants. #1, control strain (transformed with selection marker pyr5 only). M, marker. #65, chi1 transformant. The arrow marks the Chi1 protein band.



FIG. 15: Protein gel of purified heterologous Aspergillus niger PGII produced by C1. M, Marker proteins. The molecular weights of 3 marker proteins are indicated to the left of the gel. Lane 1, purified PGII.





EXAMPLES
Example 1
Isolation of C1 Mutants with Greatly Reduced Cellulase Activity (White Strains)

C1 strain UV18-25 (described in WO/2000/020555) was mutated using UV light to produce the strain UV26-2 (Appendix 1 to the Examples). UV26-2 exhibited large clearing zones on ASC (acid swollen cellulose) plates, indicating overproduction of cellulase.


UV26-2 was not a stable mutant and successive streaking of UV26-2 resulted in generation of cellulase negative mutants as shown by the absence of clearing zones on ASC plates. These colonies exhibited enhanced sporulation and white color, while normal, cellulase-producing, colonies were cream colored and showed no sporulation on ASC plates.


Two white colonies (UV26-2W1 and UV26-2W2) were picked from ASC plates along with two normal colonies and cellulase production was evaluated using a shake flask screening procedure. The white colonies produced 6 and 4 U/ml of AzoCMC cellulase activity, while the two normal colonies produced 278 and 294 U/ml of cellulase activity. This confirmed the white colonies to be cellulase-negative mutants.


Example 2
Isolation and Analysis of Protease Deficient Strains of UV26-2W1L and UV26-2W1D

The purification of strain UV26-2W1 on RM-ASP medium plates (Appendix 2 to the Examples) resulted in the identification of 2 types of colonies: colonies with light colored spores like UV18-25 (UV26-2W1L further indicated as strain W1L), and colonies with dark (pink) colored spores (UV26-2W1D further indicated as strain W1D).


In additional experiments batches of spores of both W1L and W1D were irradiated with UV (Appendix 1 to the Examples) and used in a direct selection procedure for protease-deficient mutants (Braaksma et al., 2008). Positive clones were analyzed on skim milk plates for their protease activity.


After several rounds of purification and selection on skim milk plates, two mutants of W1L (W1L#50.c and W1L#100.l) and three mutants of W1D (W1D #50.g, W1D #50.n and W1D #100.b) with a reduced halo on skim milk plates were selected for cultivation for in vitro degradation assays. In a first cultivation experiment these mutants and their parent strains were cultivated in medium #2 Appendix 1 to the Examples) for 240 hours at 35° C. Apparently, the low cellulase activity in these strains did not allow for growth in high density cellulose based medium. In following cultivation experiments W1L#50.c, W1L#100.l, W1 D #50.g and W1D #100.b and their parents were grown in low (#1) and high (#2) density cellulose medium for 240 hours at 35° C. Also UV18-25 was taken as a control. The parent strains 2W1D, 2W1L and UV18-25 were also cultivated in medium #2. None of the W1L or W1D strains grew in high density cellulose medium #2. In medium #1 good growth could be observed for the ‘white’ strains and their protease-deficient mutants, although the cellulose in the medium was hardly used by the ‘white’ strains. Unexpectedly, it was noted that the UV26-2W1D parent strain, which showed an unstable growth phenotype on agar plates, did use the cellulose in the medium.


The medium samples of the W1L parent strain showed less protease activity on skim milk plates compared to medium samples of W1D parent strain and UV18-25 (Table 1). This is contrary to what was observed when the strains were grown directly on skim milk plates. In that case a large halo could be detected around the colony of UV18-25 and of W1L after 72 hours growth at 30° C., while a small halo could only be detected after 144 hours for W1D. The medium samples of protease mutant W1D #50.g showed a smaller halo on milk plates until 162 hours of cultivation. After 186 hours cultivation, halos were similar as observed for its parent strain.









TABLE 1







Medium analysis of W1L and W1D parent strains and their selected protease mutants:


W1L#100.l, W1D#50.g and W1D#100.b. UV18-25 was taken as control. Protease


activities of medium samples of W1L, W1L#100.l and W1L#100.lΔalp1 were also de-


termined. These strains were cultivated in medium #1 (low cellulose/lactose/pharmamedia).


The pH was measured and medium was spotted on skim milk plates to determine their


protease activity. The relative size of the halo is a measure for the protease activity in


the medium.










Relative halo size (hrs of cultivation)
Protease activity















Strain
114
138
162
186
210
240
282
U/ml





W1L parent
++
++
++
++
++
++
++
943


W1L#100.l
+
+++
+++
+++
+++
+++
+++
119


W1L#100.lΔalp1
nd
nd
nd
nd
nd
nd
nd
 46


W1D parent
+++
+++
+++
+++
+++
+++
+++
nd


W1D#50.g



++
++
++
++
nd


W1D#100.b
++
++
++
++
++
++
++
nd


UV18-25
+++
+++
+++
+++
+++
+++
+++
nd





nd, not determined.






Analysis of 282 hours medium samples of these strains on SDS-PAGE gels showed that the ‘white strains’ produced much less protein than UV18-25 (FIG. 1). In particular the two major 50/70 kDa proteins (Cbh1) were absent in these culture supernatants. In the white strains the ‘major’ proteins are 75 and 45 kDa. These proteins are present in medium of UV18-25 as minor proteins.


From this first screening for protease-less mutants in a UV26-2W1 background the strains W1D #50.g and W1L#100.l were selected for further analysis.


Example 3
Comparison of Extracellular Enzyme Activities Between UV18-25 and W1L#100.l

Different enzyme activities in the extracellular protein content of UV 18-25 and W1L#100.l samples were determined (Table 2). Based on these data it was concluded that W1L#100.l secretes very little specific cellulase activity (less than 1% of UV 18-25) and has very little or no detectable protease activity when compared to UV18-25.









TABLE 2







Specific activities of samples (U/mg of protein).


Protease activities were measured at 3 different pH values.











Activities
UV18-25
W1L#100.l














CMCase (cellulase)
6.20
0.04



Beta-glucanase
10.2
0.53



Cellobiohydrolase
0.72
0.09



Protease (pH 5)
0.06
0.03



Protease (pH 7)
0.05
0.00



Protease (pH 9)
0.04
0.00









In addition, the levels of hydrolases bearing other substrate specificities (e.g. hemi-cellulose) were reduced as well.


Example 4
Further Reduction of Protein Level: Identification of Major Proteins

As described above, the white strain is missing the extracellular cellulolytic enzyme spectrum when compared to its parental strain. Hence, the extracellular protein content in white strain cultures, as analyzed by SDS-PAGE, is low. This strain characteristic is beneficial with regard to protein production and purification, since the relative amount of any target protein expressed in such strain will be high. Furthermore, the (nearly) absence of cellulase activity makes the white strain an ideal host strain for testing new or modified cellulases. The same is valid for xylanases as no major xylanase activity was detectable.


To further reduce the protein background level, several major protein bands present in an SDS-PAGE gel from a W1L#100.1 and derivative strain cultures were excised and identified by N-terminal sequencing and/or MS-MS analysis. The most abundant protein was the endochitinase Chi1 (gene identifier: CL06081, peptides MVYDYAG, MPIYGRS, and MFXEASA). Other major proteins were identified as a glucoamylase (Gla1, CL09507, peptides TGGWSVVWPVLK (SEQ ID No 1) and VVGSSSEL(I)GNWDTGR (SEQ ID No 2)), exo-chitinase (Chi2, CL00367, peptides TIDAMAWSK (SEQ ID No 3), NFLPVADILR (SEQ ID No 4), GAYHPSQTYSPEDVEK (SEQ ID No 5), and SWQLVYQHDPTAGLTAEEAK (SEQ ID No 6) and a laminarinase (Lam1, CL08253, peptides PQYESAGSVVPSSFLSVR (SEQ ID No 7) and VSGQVELTDFLVSTQGR (SEQ ID No 8). Also an alkaline protease Alp1 (CL04253) has been identified in W1L#100.l culture broth. Alp1 degrades extracellular proteins, and may degrade proteins of interest.


Example 5
Further Reduction of Protein Level: Disruption of the Chi1, Chi2, Gla1 and Lam1 Genes

The vector pChi3-4 (see Example 9, Isolation of the endochitinase 1 encoding gene) was used for the construction of the gene disruption vector. A 1.1-kb MscI/StuI fragment was replaced with the amdS-rep selection marker or the pyr5-rep selection marker, resulting in the vectors pΔchi1-amdS and pΔchi1-pyr5, respectively. The disruption fragment Δchi1-amdS was isolated from pΔchi1-amdS by digestion with EcoRI. The disruption fragment Δchi1-pyr5 was isolated from pΔchi1-pyr5 by digestion with SmaI. Transformation of strain W1L#100.lΔpyr5#172-12 using the disruption fragments resulted in 215Δchi1-pyr5 transformants and 32Δchi1-amdS transformants. All the obtained transformants were purified and analyzed with colony hybridization. Southern analysis of these transformants confirmed the isolation of one W1L#100.l transformant with a disrupted chi gene (W1L#100.1Δpyr5Δchi1-pyr5#46 (pyr5+)).


Shake flask cultures on C1 low density medium were performed from a selection of W1L#100.lΔpyr5Δchi1 mutant strains. The samples were analyzed on SDS-PAGE to evaluate the protein profiles for absence of Chi1 protein (FIG. 2, lane 2 versus lane 1). As shown no 45 kDa Chi1 protein is observed in the Δchi1 mutant strain.


The remaining most prominent extracellular proteins in white strain W1L#100.lΔalp1Δchi1 and derivative strains correspond to glucoamylase (Gla1), exo-chitinase (Chi2) and laminarinase (Lam1). These enzymes were purified from the culture medium. The enzymatic activities of these proteins were verified using (among others) starch, chitosan and laminarin, respectively, as substrates. Furthermore, mass spectrometry analyses data (see Example 4) combined with C1 genome sequence data revealed the corresponding genes. In order to further reduce the extracellular protein background, the Gla1, Chi2, and Lam1 encoding genes were disrupted and thereby inactivated. Disruption was based on the exchange of the gene promoter and part of the 5′ coding sequence by an amdS selection marker via homologous recombination using approximately 1.5 kbp upstream and downstream sequences that flank these gene promoter and part of the 5′ coding sequence. The gene disruption vectors therefore contained the amdS expression cassette plus these flanking 1.5 kb homologous gene sequences. White strains W1L#100.lΔalp1Δchi1 and derivative strains were transformed with the gla1, chi2 and lam1 gene disruption vectors and transformants were screened for the correct genotype using PCR. As such, white strains with a further reduced extracellular protein composition/content were obtained. Target proteins produced by these strains were more than 80% pure in the crude cell-free culture liquid.


Example 6
Further Reduction of Protease Activity: Targeted Disruption of Genes Encoding Proteases

In general, protease encoding genes were disrupted using disruption DNA fragments that contained selection markers (amdS, pyr4 or pyr5) flanked by approximately 1.5 kb large DNA fragments homologous to regions up- and downstream of the gene to be disrupted. Upon introduction of these disruption DNA fragments into the white host, an homologous recombination exchanged the gene to be disrupted for the selection marker fragment. Corresponding transformants were selected as such. Genes that were disrupted this way either encoded disadvantageous (with regard to target protein stability) protease activities e.g. alp1, alp2, pep4) or significant background protein (chi1) or were to be used as selection marker (pyr4, pyr5). Via this approach numerous white C1-strains have been constructed that can be used as hosts for target protein expression (Table 3).









TABLE 3





Strain W1L and derivatives.

















W1L



W1L SUIR #S2 6.14



W1L SUIR #S2 6S



W1L#100.l



W1L#100.l Δpyr5



W1L#100.l Δalp1



W1L#100.l Δalp1 Δpyr5



W1L#100.l Δpep4 Δpyr5



W1L#100.l Δalp1 Δpep4



W1L#100.l Δalp1 Δpep4 Δpyr5



W1L#100.l Δalp1 Δalp2 Δpyr5



W1L#100.l Δchi1



W1L#100.l Δalp1 Δchi1



W1L#100.l Δalp1 Δchi1 Δpyr5



W1L#100.l Δalp1 Δchi1 Δalp2



W1L#100.l Δalp1 Δchi1 Δalp2 Δpyr5



W1L#100.l Δalp1 Δchi1 Δpep4



W1L#100.l Δalp1 Δchi1 Δgla1Δlam1Δchi2Δpyr5









Example 7
Identification of Strong Promoters for Gene Expression: Chitinase Encoding Gene (chi1)

Several major protein bands were isolated from fermentation samples of W1L#100.l grown in low density cellulose medium in order to identify and isolate strong promoters that can be used for gene expression in the W1L strain and its derivatives. N-terminal sequencing of a mixture of peptides obtained after CNBr treatment of the major 45 kDa protein of W1L#100.1 resulted in the identification of four different peptides. Three of these peptides (MVYAG, MPIYGRS and MFXEASA) showed homology with an endochitinase of Aphanocladium album/Trichoderma harzianum (CHI_APHAL P32470).


Based on 3 of these peptide sequences, primers were designed in order to obtain PCR fragments containing a part of the endochitinase encoding gene (Table 4). The PCR primers were designed based on the preferred codon usage of C1.









TABLE 4







The designed primers of putative endochitinase


based on codon usage of C1.












Posi-
Deduced


Primer
Region
tion
sequence





Endochitpep1C
MVYDYAG
240 aa
ATGGTSTACGACTA



(SEQ ID

CGCBGG



No 9)

(SEQ ID No 10)





Endochitpep2C
MPIYGRS
290 aa
ATGCCSATCTACGG



(SEQ ID

YCG



No 11)

(SEQ ID No 12)





Endochitpep2revC


CGRCCGTAGATSGG





CAT





(SEQ ID No 13)





Endochitpep3revC
MFXEASA
380 aa
GCSSWVGCCTCCCA



(SEQ ID

GAACAT



No 14)

(SEQ ID No 15)










Primer based on a conserved homologous region


of endochitinase:










Endochit3c
DGIDIDWEV
160 aa
GAYGGYATCGAYRT



(SEQ ID

SGAYTGGG



No 16)

(SEQ ID No 17)









PCR reactions with these primers were carried out using chromosomal DNA of UV 18-25 as template DNA. PCR fragments were cloned and sequence analysis showed that one of the cloned PCR fragments obtained with Endochitpep1c and Endochitpep2revc (173 bp) contained a part of an endochitinase-encoding gene (chi1). Hybridization analysis of chromosomal DNA of UV18-25 digested BamHI and HindIII with this chi1 fragment as probe showed a clear hybridization signal confirming that the PCR fragment originated from C1 DNA. This fragment was used to clone the complete gene from the ordered C1-cosmid gene library. The fragment sequence (SEQ ID No 18) was as follows:









ATGGGCTACGACTACGCCGGCTCGTGGAGCACCGCGGCGGGACACCAGG





CCAACCTGTACCCGACCGCCGACGCGGGCAGGACGCCCTTCTCGACCGA





CAAGGCCCTGTCCGACTACGTCGCCGCCGGCGTCGACCCGGCCAAGATC





GTGCTCGGCATGCCCATCTACGGCCG






Example 8
Construction of an Ordered Cosmid Library of Chrysosporium Lucknowense UV18-25 in E. Coli

For the construction of the C1 cosmid library the non commercial cosmid cloning vector, pAOpyrGcosarp1 (FIG. 3) was used. This vector carries the Aspergillus oryzae pyrG selection marker allowing transformation of a wide range of fungal strains. Moreover, for highly efficient transformation of various Aspergillus species (for which a large collection of mutant strains is available for complementation cloning of the corresponding C1 gene) the AMA 1-replicator is present in this vector. A unique BamHI cloning site allows cloning of partially Sau3A digested genomic DNA from Chrysosporium strain UV 18-25.


A cosmid library of UV 18-25 was constructed in E. coli and stored as glycerol stocks in the −80° C. The average insert size was 20-35 kb. In total, 6800 clones were obtained, which represents a genome coverage of about 5 fold. To order these clones in 384-wells plates, dilutions of the glycerol stocks were plated on LB-agar plates, containing ampicillin. 7680 individual colonies were manually picked and inoculated in twenty 384-wells plates. These twenty 384-wells plates represent the ordered cosmid library of UV 18-25 in E. coli.


The individual colonies in the twenty 384-wells plates were spotted on nylon filters (Hybond), using a Staccato 384-pintool (Zymarks). The ordered cosmid library was spotted in octuplicate (in total 160 filters). These filters were placed on LB-ampicillin medium plates and incubated at 37° C. to allow colonies to grow on the filters. Subsequently, the colonies were lysed and the cosmid DNA was bound to the filters using standard procedures.


Example 9
Isolation of the Endochitinase 1 Encoding Gene (chi1)

The 173-bp chi1 PCR fragment was used as a radio-active labelled probe for hybridization of duplicate filters of the cosmid library. Hybridization of the cosmid gene library using this chi1 fragment resulted in 3 positive clones. DNA was isolated from these clones and restriction analysis followed by Southern analysis was carried out. A 4.8 kb HindIII fragment and a 3.4 kb BglII fragment showed hybridization using the chi1 probe. The 4.8 kb HindIII and 3.4 kb BglII fragments containing the chi1 gene were isolated and subcloned in pMTL24, resulting in the vectors pCHI4.8 (FIG. 4) and pChi3-4, respectively. Subsequently, a BglII sub-clone was used for sequence analysis to obtain more sequence data. The sequence of the complete chi1 gene of UV 18-25 was obtained. The size of the chi1 gene is 1529 bp in which 2 introns of 111 bp and 138 bp are present.


Example 10
Overexpression of the Endochitinase in W1L#100.l

For overexpression of endochitinase the 3.4 kb BglII fragment containing the chi1 gene was isolated from pChi3-4. Putative chi1 multi-copy strains in W1L#100.lΔpyr5 were generated by co-transformation of the 3.4 kb BglII chi1 fragment and a pyr5 selection fragment and correct transformants were confirmed by colony hybridization. Shake-flask cultures on C1 low density medium were performed from a selection of W1L#100.l chi1-multicopy strains. The samples were analyzed on SDS-PAGE to evaluate the protein profiles for the overproduction of Chi1 (FIG. 5). Three of the multi-copy chi1 strains (lanes 3, 4, 5) show a stronger 45 kDa band compared to the parent strain (lane 1) indicating chitinase overexpression and the usefulness of the chi1 promoter for high gene expression.


Therefore, a general C1 expression cloning vector (pPchi1(0.8)-Tcbh1 NotI) was constructed containing the chi-promoter (Pchi) to direct the overexpression of cloned genes. Initially, the EcoRI site upstream op Pchi1 in pCHI #4.8 was removed by a partial EcoRI digestion and treatment of the linear fragment with Klenow yielding pCHI1#4.8ΔEcoRI. From this vector the 1.9-kb SacI-SphI fragment was cloned in the corresponding site of pPcbh1-glaA(II)-Tcbh1 (FIG. 6). In the resulting vector, pPchi-Tcbh1 NotI #7.1, the target genes can be inserted into the NcoI-EcoRI sites. Expression cassettes for transformation into C1 strains can be isolated from these constructs as NotI fragments.


The 0.8 kb chi1 promoter sequence in pCHI #4.8 could be more than sufficient to drive chi1 expression. However, a longer chi1 promoter was also generated by amplifying the a PstI-HindIII fragment (upstream of the HindIII site at position −775 relative to the ATG start codon), using one of the previously identified positive cosmid clone as template DNA. The resulting fragment was cloned in pGEM-T-Easy and sequenced. From this plasmid the PstI-HindIII fragment was isolated and cloned in the corresponding sites of pPchi1-xyl1-Tcbh1 yielding pPchi1(1.8)-xyl1-Tcbh1, in which the promoter size is 1.8 kb. The fragment was also cloned in the corresponding site of pPchi1-Tcbh1 NotI #7.1, yielding the general expression vector pPchi1(1.8)-Tcbh1 NotI (FIG. 7).


The levels of gene expression directed by the extended chitinase promoter (Pchi1(1.8)) and by the initially used chitinase promoter (Pchi1 (0.8)) were compared by the expression of two reporter genes, xyl1 and alp1. White strain transformants were generated that either expressed xyl1 (encoding a xylanase) or alp1 (encoding an alkaline protease) (Table 5).









TABLE 5







Comparison of the short and extended Pchi1 promoters in terms of


reporter protein expression level. Reporter activity, xylanase activity is


expressed as U/ml and alkaline protease activity as U/mg of protein.












0.8 kb Pchi1
1.8 kb Pchi1



Reporter
Reporter activity
Reporter activity






Alp1 (R19)
 0.7 (A)
  1.9 (B)



Xyl1 (R14)
122 (C)
1175 (D)





A = W1L#100.l[Pchi1(0.8)-alp1/pyr5]#9, B = W1L#100.l[Pchi1(1.8)-alp1/pyr5]#22, C = W1L#100.lΔalp1[Pchi1-xyl1]#95, D = W1L#100.lΔalp1[Pchi1(1.8)-xyl1]#A7.






Surprisingly, the reporter gene expression was higher in case of the extended chi1 promoter (1.8 kb), which indicates the necessity of the further upstream regions. In conclusion, a Pchi1 based expression system was developed for high level expression of genes in White C1 strains.


Example 11
Identification of Other Strong Promoters for Gene Expression

A different approach for searching strong promoters was performed using the quantitive detection of messenger RNA levels from W1L or W1L#100.1 RNA. The RNA samples were isolated from mycelium which was sampled at different time points during a fed-batch fermentation process. A number of genes were identified as being strongly or stronger expressed. To verify the expression level of these genes, the RNA samples were also separated on gel, blotted and hybridized to probes specific for these genes (Table 6).









TABLE 6







Quantification of the expression signals of the different genes


in controlled fed-batch fermentations. Probe hybridisation signals


were quantified using a densitometer. The signal of the probe on


on the Northern blot was correlated with the signal of this probe on a


C1 genomic DNA Southern blot. Therefore, the values in the table


represent the northern hybridization signal level relative to the


hybridization signal level from the Southern blot (which was set at 1).


Gene sequences are given below.














Strain/feed
chi1
pep4
his2a
hex1
bgl1
xyl6
cbh1

















W1L/glucose









Batch
0
4
2
21
0
0.3
0


Day 1 feed
47
5
3
15
8
1
0


Day 2 feed
52
3
3
17
8
1
0


W1L#100.l/xylose









Batch
0
0.2
2
12
0
0
0


Day 1 feed
40
3
2
12
3
19
0


Day 2 feed
36
4
6
17
5
21
0


W1L#100.l/glucose









Batch
0
0.1
3
23
0
0.1
0


Day 1 feed
61
0.5
2
17
7
0.2
0


Day 2 feed
59
0.2
2
14
6
1
0









The cbh1 promoter, which is a strong promoter in UV 18.25 strains, is not active in the white strains. The chi1 promoter was the strongest both under glucose and xylose feed conditions. The hex1 promoter is a strong constitutive promoter during all phases of fermentation and under both sugar feed conditions. The xyl6 promoter is highly active under the xylose feed condition only. The pep4, his2a and bgl1 promoters are moderately active. For high level gene expression in the white strains the chi1, hex1 and xyl6 promoters are very useful. Alternative promoters that also give high expression are those of the pep4, his2a and bgl1 genes. Additional northern experiments also indicated that the promoters of the xyl 4 and xyl8 genes can be used for high level gene expression in the white strains when grown on xylose. Glucoamylase (Gla1, gene identifier: CL09507) has been shown to be a major protein in white C1 strains. The gla1 promoter is therefore also a good candidate to be used for the high level expression of genes of interest in white strains. It was shown that glucoamylase was highly abundant in a white strain grown in the presence of starch. This indicated that the gla1 promoter is strong and inducible by starch and its degradation products, like maltose.


The nucleotide sequences of Pchi1(0.8), Pchi1(1.8), Phex1, Pxy16 and Pgla1 are given below. Note that the ATG start codons of the corresponding coding regions are given in bold italics.


Example 12
White Strain Gene Expression System

Two expression vectors were designed for expression of genes in W1L and derivatives: pPchi1(1.8)-Tcbh1 Not1 was as described above. Additionally, pCRS Pchi1-Tcbh1 (FIG. 8) was constructed by placing the C1 repeat sequence in front of the Pchi1 promoter in pPchi1(1.8)-Tcbh1 NotI. These vectors have been designed in such a way that they also can be combined resulting in a single vector that contains multiple expression cassettes. The multiple cassettes can be excised from the vector as a single linear DNA fragment.


Many genes have been cloned and expressed in W1L or derivatives. The general procedure was as follows:

    • Genes were identified by purification and characterization of the gene products (reverse genetics) and/or by genome mining. The genes were amplified by PCR or synthesized chemically. Amplification of genes by PCR was performed by using proof-reading PCR DNA polymerases (Phusion or Supertaq plus). The amplified genes were cloned into PCR cloning vectors i.e. pGEM-T-Easy (Promega) or pJet1 (Fermentas) and sequenced to verify the correctness of the sequence. Subsequently, the genes were released from the PCR cloning vector and ligated into the NcoI and EcoRI sites of the expression vector(s).
    • Special care was taken when designing the PCR primers. The ATG-start codon of the gene to be expressed was part of the NcoI restriction site in the white strain expression vectors. Therefore, the 5′ (ATG) PCR primers contained restriction sites, which are compatible to the restricted NcoI site of the vector. These sites were i.e. NcoI itself (C ICATGG), or compatible sites that are cut within the recognition site (BspHI, T↓CATGA; PciI, A↓CATGT), or compatible sites that are cut outside the recognition site (BsaI, GGTCTC(1/5); BspMI, ACCTGC(4/8); Esp3I, CGTCTC(1/5)).
    • In some cases, restriction sites additional to those that were going to be used for cloning of the genes were encountered in the genes. In these cases, the genes were amplified by fusion PCR, where the fusion of the two PCR fragments was selected to take place at the undesired additional restriction site. The undesired restriction site was removed by using fusion primers containing single substitution mutations in the undesired restriction site sequence. In case the undesired restriction site was present within a protein coding region, the substituted nucleotide was selected in such a manner that the mutant codon encoded the same amino acid as the original codon.
    • The expression cassettes were released from the E. coli DNA vector backbone by NotI restriction. The expression cassette was subsequently transformed in to W1L derivatives simultaneously with a selection marker i.e. pyr5 or amdS in co-transformation experiments.
    • Positive and high producing transformants were selected by SDS-PAGE or enzyme assay analysis of the growth medium. Best producers were applied in fermentations to produce high amount of the desired gene product.
    • The following proteins have been produced using the white strain gene expression system and corresponding genes


In the international patent application WO 2009/018537 has been described:

    • Abf1, Abf2, Abn1, Axe1, Bgl1 (=Bgl3A), Cbh1, Cbh2, Cbh4, Chi1, Eg2, Eg5, FaeA1, FaeA2, FaeB2, Gal1 (=Ga153A), Gla1 (=Gla15A), Pme1, Xyl1, Xyl1(cd), Xyl2, Xyl3, Xyl3-cbd (=xyl3(cd)), Xyl4, Xyl5, Xyl6.


In the international patent application WO 2009/033071 has been described:


Abf3, Abn2, Abn3, Abn4, Abn5, Abn7, Abn9, Agu1, Axe2, Axe3, Bga2, Bxl1, Bxl2, Abf5(formerly known as Bxl3), GH61 genes (gene identifiers: CL09768, CL10518, CL05022, CL04725, CL04750, CL06230, CL05366), Gln, Pgx1, Rga1, Rgx1, Xgl1, Xyl7, Xyl8, Xyl9, Xyl10, Xyl11.


Alp1: The Alp1 DNA sequence is given by SEQ ID NO 30. The Alp1 amino acid sequence is given in SEQ ID NO 31.


The alp1 gene was expressed and Alp1 showed protease activity (Table 5). The “Protease colorimetric detection kit” (Sigma, product number PC0100) was used to determine Alp1 protease activity.


Example 13
Expression of C1 GH61-Family-Encoding Proteins Genes

A GH61 protein-encoding gene (identifier CL10518) was overexpressed in C1 strains W1L#100.L Δalp1Δpyr5 and W1L#100.lΔalp1Δchi1Δpyr5. Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with Coomassie brilliant blue (CBB). The CL10518 protein is ±26 kDa (FIG. 9). A standard fed batch fermentation was conducted, which yielded 13 g protein per liter fermentation filtrate, based on a BCA protein determination assay.


The functional analysis of this protein has been described in International patent application WO 2009/033071.


Example 14
Expression of a C1 Cellulase-Encoding Gene: Cbh2

The CBH2 encoding gene (identifier CL09854) was overexpressed in C1 strain W1L#100.L Δalp1Δpyr5. Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with coomassie brilliant blue (CBB). The CBH2 protein migrates at about 55 kDa (FIG. 10). A standard fed batch fermentation was conducted, which yielded 10 g protein per liter fermentation filtrate, based on a BCA protein determination assay.


The functional analysis of this protein has been described in International patent application WO 2009/018537.


Example 15
Expression of C1 Exo-Polygalacturonase Encoding Gene Pgx

The PGX encoding gene (identifier CL10389) was overexpressed in C1 strain W1L#100.L Δalp1Δchi1Δpyr5. Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with coomassie brilliant blue (CBB). The PGX protein migrates at about 60 kDa (FIG. 11). A standard fed batch fermentation was conducted, which yielded 9 g protein per liter fermentation filtrate, based on a BCA protein determination assay.


The following assay was used to measure polygalacturonase activity. This assay measures the amount of reducing sugars released from polygalacturonic acid (PGA) by the action of a polygalacturonase. One unit of activity was defined as 1 μmole of reducing sugars liberated per minute under the specified reaction conditions.


Reagents






    • Sodium acetate buffer (0.2 M, pH 5.0) is prepared as follows. 16.4 g of anhydrous sodium acetate or 27.2 g of sodium acetate*3H2O is dissolved in distilled water so that the final volume of the solution to be 1000 mL (Solution A). In a separate flask, 12.0 g (11.44 mL) of glacial acetic acid is mixed with distilled water to make the total volume of 1000 mL (Solution B). The final 0.2 M sodium acetate buffer, pH 5.0, is prepared by mixing Solution A with Solution B until the pH of the resulting solution is equal to 5.0.

    • Polygalacturonic acid (PGA) was purchased from Sigma (St. Louis, USA).

    • Reagent A: 10 g of p-Hydroxy benzoic acid hydrazide (PAHBAH) suspended in 60 mL water. 10 mL of concentrated hydrochloric acid was added and the volume is adjusted to 200 ml. Reagent B: 24.9 g of trisodium citrate was dissolved in 500 ml of water. 2.2 g of calcium chloride was added as well as 40 g sodium hydroxide. The volume was adjusted to 2 L with water. Both reagents were stored at room temperature. Working Reagent: 10 ml of Reagent A was added to 90 ml of Reagent B. This solution was prepared freshly every day, and store on ice between uses.


      Using the above reagents, the assay is performed as detailed below.


      Enzyme Sample

    • 50 μL of PGA (10.0 mg/mL in 0.2 M sodium acetate buffer pH 5.0) was mixed with 30 μL 0.2 M sodium acetate buffer pH 5.0 and 20 μL of the enzyme sample and incubated at 40° C. for 75 minutes. To 25 μL of this reaction mixture, 125 μL of working solution was added. The samples were heated for 5 minutes at 99° C. After cooling down, the samples were analyzed by measuring the absorbance at 410 nm (A410) as AS (enzyme sample).


      Substrate Blank

    • 50 μL of PGA (10.0 mg/mL in 0.2 M sodium acetate buffer pH 5.0) was mixed with 50 μL 0.2 M sodium acetate buffer pH 5.0 and incubated at 40° C. for 75 minutes. To 25 μL of this reaction mixture, 125 μL of working solution was added. The samples were heated for 5 minutes at 99° C. After cooling down, the samples were analyzed by measuring the absorbance at 410 nm (A410) as ASB (substrate blank sample).


      Calculation of Activity

    • Activity is calculated as follows: determine polygalacturonase activity by reference to a standard curve of galacturonic acid.

      Activity (IU/ml)=ΔA410/SC*DF

    •  where ΔA410=AS (enzyme sample)—ASB (substrate blank), SC is the slope of the standard curve and DF is the enzyme dilution factor.





The ΔA410 of Pgx1 (CL10389) was found to be 0.78 with a DF of 1 for enzyme produced in microtiter plate cultures. No standard curve was analyzed, therefore no reliable activity can be calculated. The only conclusion to be drawn is that the enzyme was found to be active towards polygalacturonic acid, and therefore it is suggested that it is a polygalacturonase.


The functional analysis of this protein has been described in International patent application WO 2009/033071.


Example 16
Expression of a C1 Xylanase Encoding Gene with and without its Carbohydrate Binding Domain: Xyl1

The Xyl1 encoding gene (identifier CL00649) was overexpressed in C1 strain W1L#100.L Δalp1Δchi1Δpyr5. Two Xyl1 variants were produced: either full length Xyl1 or Xyl1 without its carbohydrate binding domain (cbd). Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with coomassie brilliant blue (CBB) (FIG. 12). The Xyl1 protein migrates at about 40 kDa, while its CBD-less counterpart migrates at about 30 kDa. Standard fed batch fermentations were conducted, which yielded up to 33 g protein per liter fermentation filtrate, based on a Bradford protein determination assay. Xylanase activities of these filtrates reached up to 3,500 U/mL.


The following assay is used to measure the xylanase activity towards AZO-wheat arabinoxylan. This substrate is insoluble in buffered solutions, but rapidly hydrates to form gel particles which are readily and rapidly hydrolysed by specific endo-xylanases releasing soluble dye-labeled fragments.


Reagents






    • Sodium acetate buffer (0.2 M, pH 5.0) is prepared as follows. 16.4 g of anhydrous sodium acetate or 27.2 g of sodium acetate*3H2O is dissolved in distilled water so that the final volume of the solution to be 1000 mL (Solution A). In a separate flask, 12.0 g (11.44 mL) of glacial acetic acid is mixed with distilled water to make the total volume of 1000 mL (Solution B). The final 0.2 M sodium acetate buffer, pH 5.0, is prepared by mixing Solution A with Solution B until the pH of the resulting solution is equal to 5.0.

    • AZO-wheat arabinoxylan (AZO-WAX) from Megazyme (Bray, Ireland, Cat. #I-AWAXP) is used as the assay substrate. 1 g of AZO-WAX is suspended in 3 mL ethanol and adjusted to 100 mL with 0.2 M sodium acetate buffer pH 5.0 using magnetic stirrer. 96% Ethanol is used to terminate the enzymatic reaction.


      Using the above reagents, the assay is performed as detailed below:

    • Enzyme Sample

    • 0.2 mL of 10 mg/ml AZO-WAX stock solution was preheated at 40° C. for 10 minutes. This preheated stock solution was mixed with 0.2 mL of the enzyme sample (preheated at 40° C. for 10 min) and incubated at 40° C. for 10 minutes. After exactly 10 minutes of incubation, 1.0 mL of 96% ethanol was added and then the absorbance at 590 nm (A590) was measured as AS (enzyme sample).


      Substrate Blank

    • 0.2 mL of 10 mg/ml AZO-WAX stock solution was preheated at 40° C. for 10 minutes. This preheated stock solution was mixed with 200 μl of 0.2 M sodium acetate buffer pH 5.0 (preheated at 40° C. for 10 min) and incubated at 40° C. for 10 minutes. After exactly 10 minutes of incubation, 1.0 mL of 96% ethanol is added and then the absorbance at 590 nm (A590) is measured as ASB (substrate blank).


      Calculation of Activity

    • Activity is calculated as follows: determine endo-xylanase activity by reference to a standard curve, produced from an endo-xylanase with known activity towards AZO-WAX.

      Activity (IU/ml)=ΔA590/SC*DF

    •  where ΔA590=AS (enzyme sample)—ASB (substrate blank), SC is the slope of the standard curve and DF is the enzyme dilution factor.





The functional analysis of this protein has been described in International patent application WO 2009/018537.


Example 17
Expression of the C1 Arabinase 2 Encoding Gene Abn2

The Abn2 encoding gene (identifier CL03602) was overexpressed in C1 strain W1L#100.L Δalp1Δchi1Δpyr5. Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with coomassie brilliant blue (CBB). The Abn2 protein migrates at about 50 kDa (FIG. 13). A standard fed batch fermentation was conducted, which yielded 7 g protein per liter fermentation filtrate, based on a BCA protein determination assay.


The functional analysis of this protein has been described in International patent application WO 2009/033071.


Example 18
Expression of the C1 Endo-Chitinase Encoding Gene Chi1

The Chi1 encoding gene (identifier CL06081) was overexpressed in C1 strain W1L#100.L Δalp1Δpyr5. Culture supernatant samples were analyzed by SDS-PAGE and protein bands were stained with coomassie brilliant blue (CBB). The Chi1 protein migrates at about 40 kDa (FIG. 14). A standard fed batch fermentation was conducted, which yielded 12 g protein per liter fermentation filtrate, based on a BCA protein determination assay.


The functional analysis of this protein has been described in International patent application WO 2009/018537.


Example 19
Expression of a Heterologous Gene: Aspergillus Niger Poly-Galacturonase II

The Aspergillus niger poly-galacturonase II encoding-gene (accession number X58893) was expressed in C1 strain W1L#100.lΔalp1Δchi1Δpyr5. After fermentation the enzyme was purified using ion exchange chromatography and size exclusion chromatography. The purified endo-PGII migrated at about 40 kDa on SDS-PAGE gel (FIG. 15).


This heterologous enzyme was functional as was shown by activity on polygalacturonic acid using the following assay.


Reducing Sugars Assay: PAHBAH Method


Stock Solutions:






    • Substrate: 1% (w/v) polygalacturonic acid in H2O.

    • Reagent A: p-Hydroxy benzoic acid hydrazide (PAHBAH) (10 grams) is added to 60 ml of water and slurried. To this is added 10 ml of concentrated HCl and the volume is made up to 200 ml. Reagent B: Dissolve trisodium citrate (24.9 g) in 500 ml of water, add calcium chloride (2.20 g) and dissolve, add sodium hydroxide (40.0 g) and dissolve. Adjust the volume to 2 liters. The solution should be clear. Store both reagents at room temperature. Working Reagent: add 10 ml of Reagent A to 90 ml of Reagent B. Prepare this solution fresh daily, and store on ice between uses.


      Assay:

    • 1. 50 μl substrate

    • 2. 30 μl 0.2M HAc/NaOH pH 5.0

    • 3. 20 μl sample/enzyme (microplate undiluted; fermentor >20× diluted)

    • 4. Incubate at 37° C. for 10 minutes

    • 5. 25 μl assay mix+125 μl Working Reagent (in PCR microplate) or 50 μl assay mix+250 μl Working reagent (in 1.5-ml tube)

    • 6. Heat @ 99° C. for 5 minutes in Thermal PCR Cycler (PCR microplate) or in boiling water (1.5-ml tube)

    • 7. Transfer 100 μl to NUNC microplate and measure extinction @ 410 nm





Example 20
Generation of Artificial Enzyme Mixes for Efficient Plant Biomass Saccharification

An artificial enzyme mixture was created by mixing crude protein from C1 UV18-25Δalp1 with crude protein from white strains expressing C1-β-glucosidase Bgl1, C1-arabinofuranosidase Abf3 and Abn7, C1-xylanase Xyl2 and C1-β-xylosidase Bxl1, being W1L#100.LΔalp1Δpyr5[Bgl1/pyr5], W1L#100.LΔalp1Δchi1Δpyr5[Abf3/pyr5], W1L#100.LΔalp1Δchi1Δpyr5[Abn7/pyr5], W1L#100.LΔalp1Δpyr5[Xyl2/pyr5], and W1L#100.LΔalp1Δchi1[Bxl1/AmdS], respectively. The ratio of the different components on a protein basis was 10 (UV18-25Δalp1): 1 (white strain proteins).


The saccharification efficiency of the crude protein from UV18-25Δalp1 alone was tested on wheat bran substrate and compared to the efficiency of the artificial mixture. 10 mg protein/g dry matter wheat bran was used. Conditions were as follows: temperature 50° C., pH 5.0, time 72 hours.


It was shown that the enzyme mixture from UV18-25Δalp1 alone liberated approximately 30% of the glucose, approximately 5% of the xylose and 12% of the arabinose from the wheat bran. The artificial mixture liberated at least 60% of the glucose, 60% of the xylose and 25% of the arabinose from the wheat bran.


Example 21
Construction of Gene Libraries in white C1 Strain W1L#100.l.Δalp1Δchi1Δpyr5 and Screening of Xylanases

A gene library from genomic DNA of C1 strain UV18-25 was constructed in C1-strain W1L#100.lΔalp1Δchi1Δpyr5 by methods previously described by Verdoes et al. (2007). The library was screened for xylanase activity as described by Example 4 in chapter 4, which yielded several positive clones that expressed different xylanases. SDS-page analysis revealed the presence of extra protein bands in the positive clones. PCR analysis using different primer combinations based on the sequence of the known C1 xylanases and the vector sequence revealed the presence of 3 different C1-xylanases. This result was confirmed by Southern analysis.


Appendix 1 to the Examples: UV Mutation Procedure for C1 Strains




  • 1. Spread parent strain onto PDA (potato dextrose agar) plates and incubate at 35° C. for 14 days to obtain spores.

  • 2. Scrape spores into 0.9% saline and filter through cotton to remove mycelia. Dilute the resulting spore suspension to 1×106 spores/ml using saline. Remove a small aliquot of spore suspension, dilute in saline and spread plate to PDA to determine the initial viable spore count.

  • 3. Add 10 ml spore suspension to a sterile glass Petri dish containing a paper clip and stir on a magnetic stir plate. Remove the glass top and irradiate with UV light to obtain 90-99.9% kill. Use a Pen-Ray lamp as the UV light source (254 nm) and warm it up for at least 10 minutes prior to irradiating the spore suspension.

  • 4. Spread plate to ASC selective plates (Appendic 2 to the Examples) with room lights off, using a volume to obtain less than 30 colonies on each plate.

  • 5. Invert plates, put in red plastic bags and incubate at 30° C. for 6-7 days to grow and allow clearing zones to develop.

  • 6. Determine % kill for the mutation as the difference between the initial viable plate count and a plate count on PDA after UV irradiation.


    Appendix 2 to the Examples: Media


    ASC Selective Agar Plates
















Component
Amount



















Deionized water
800
ml



K2HPO4
1.0
g



KCl
0.1
g



NaCl
0.1
g



MgSO4—7H2O
0.3
g



FeCl3—6H2O
0.016
g



(NH4)2SO4
1.9
g



20 g/l ASC
200
ml



Noble Agar
15
g










Adjust pH to 7.5 with HCl and sterilize 30 minutes at 121° C. After sterilization add 20 ml of 25 g/l DOC (deoxycholic acid), sterile filtered. Pour about 20 ml/plate. Spread UV-mutated spores to ASC plates and incubate for 7-14 days to allow colony growth and cellulose clearing.


RM-ASP Medium















Component
Amount



















Bacto Peptone
2
g



Bacto Yeast Extract
1
g



50x AspA (+N)
20
mL



Glucose
10
g



1000x trace elements
1
mL



MgSO4—7 H2O
0.493
g










Water
Bring total volume to 1 L.









Adjust pH to 6.5 prior to autoclaving. Sterilize glucose separately as a 50% solution.















Component
Amount















50x AspA (+N)











NaNO3 (or (NH4)2SO4)
300 (or 233)
g



KCl
26
g



KH2PO4
76
g



KOH 10N
22.5
mL










Water
Bring total volume to 1 L.







1000x trace elements











ZnSO4—7H2O
2.2
g



H3BO4
1.1
g



MnSO4—H2O
0.427
g



FeSO4—7H2O
0.5
g



CoCl2—6H2O
0.17
g



CuSO4—5H2O
0.16
g



Na2MoO4—2H2O
0.15
g



EDTA
5
g










Water
Bring total volume to 100 mL.










Low and High Density Cellulose Media















Low density cellulose
High density cellulose


Component (g/L)
medium (#1)
medium (#2)

















BisTris
15.7
15.7


K2HP04
0.22
0.66


KH2P04
0.08
0.24


(NH4)2SO4
4
12


Na3Citrate•H2O
4
12


MgS04•7H2O
0.03
0.09


CaCl2
0.4
0.8


Yeast Extract
0.05
0.15


Pharmamedia
5
15


Lactose•H2O
5
15


Cellulose
20
80










Adjust to pH 7.0.










chi1 sequence: see WO 2009/018537.






pep4 DNA sequence (SEQ ID No 19):









1
gctggctcaccgttatttgctcccgcaggaagtccaggtcctcctcgcagttggacaaac






61
tctgcttcgcagcctgcaactttgactcaaggagcgcctcggcctcgtcgattgggtaag





121
acagcatgacgttggcctgccaaatgtcagcctctagaagcacactcccactctcgttgg





181
aaaggttcctaccccaagccacaagtaaacctcgtccgtcggcggtatctcggccttcgc





241
atagagagtgtcgttcaattcgaatgttgtctctatcggatcagattcgccctgccacaa





301
tcaaccgccgatcagcaccatggccgctcatcgagagtggcaacgcctcgccctaccgtc





361
ctcagcttcaaaaagcggacagcctccagcgttttccgaatgtcgggcattttgtccttt





421
agtcccgctaccctccgctgcaggttctgctccatgaactggtatttcctgcacgccgac





481
cacgtatcagccgaacgccgtccgtcaaggctggatttcaatcttaaccgggagagctca





541
cgcaatcatctcttggaaccgacgcagcgtcggctcaacatctgctcgtgacgtgacata





601
gtcctcgaccttgtcgacgaatggcgcatacggaatgccacgaggattggagggtgtggc





661
gtccctgtctcgtgcaggtggtcagtcagcaataacagccagagtgcatatgctagaatg





721
gcgcccgcgggggagggaaagtttggttaccttgctgctgcttccttgtctgtgctcgcc





781
atcttggacaaattctcacatgttgcagtggaaggatactgcaagcgactgttaacccga





841
gccaacggagtgacgtcgggtttggtacctagtttaggtcaagccgttctcaagctgctg





901
gccaaaaattcatggcggggtcgagtgggcagcgaggtactcctcgtagggagcaaggtg





961
aagatgtggggtagcaggggtcgacgctacaaagtactttgtatccggattgctgtgtgg





1021
tacgaagcgcccgtgtgttggatgctctctgtatgtacggagtactgtacctttctccat





1081
gcgctgccccattctctatttggttgcacctgcttcgttcgtagtgtatgtacagcagta





1141
caactatctacgacacctgcactgactagtgcgtagaattctttagtttctcgagtacgg





1201
cgctaacgcttcgcgcagcaagcaccttcttctgattgtgttactgtgctcaaacctcgc





1261
cagccagctgcggtgctccacaagcccggccgtgcccaaccgccatttgcatcccggtcc





1321
catgaatctgtggacgacccatccctctctgtaccgcgtcgcggtatcagcccagaatga





1381
tagcgggaagacaaacgcagtgattcggattacgctcgcaggaaatggggggagtagctt





1441
gatagctctccacggcgagggtgtctcaggctgaggtgtcaactagttgtatgtacactc





1501
aggacgaggcattctgcgttttgaaacaccaatcttccaataccggaggtgttgtatgca





1561
ggatcacttgaatatgtttgcacccattattactgtacctggatgattcggacagggcga





1621
gcatgattggtcgccccgttttgtcaccgcattcgcagcgtcggcgggaagcagccacgt





1681
agagcactgccaaacgtttcaagagacaccccatatggagtaaattggagtaatctgtat





1741
ccttcagagccgtcaatcaaactattgtttctcagcaggatggcccgttgctcatggggg





1801
atgtaccctggtaggtagttcgttgttgatgacttccttggatgagcctgctgcgcatga





1861
aggtgccggggccccaggttgggtgcctaaaactaactgtaaacagacgcacggtggcga





1921
cgacgtagccgaaccggtgtagcgagctttccccggccactacgtaatcggggcgatgca





1981
ctgcaggaacacctcacacctgacctacccccttcgcctccgcatccgtcccaacccgct





2041
tccccaacctttccatcaactacttccgagactcgacatcaccttttcgcgtcgtgtctc





2101
atcgtcgttatcatcaccatcggcgatagatttgttcgcttcgatcgtcgcatcgccttg





2161
acttccattcgtccttcacgccgaccgaccggaccagacagtcgcccaaaATGAAGGATG





2221
CTTTTTTGCTGACCGCAGCTGTGCTGCTCGGCTCCGCCCAGGGAGCAGTTCACAAAATGA





2281
AGCTGCAGAAGATCCCTCTCTCTGAGCAGCTTgtacgtctgaccccgttcaagcacgcgt





2341
cagcggctactgaccttatcgcgtccagGAGGCGGTTCCCATCAACACCCAGCTCGAGCA





2401
TCTCGGCCAAAAATACATGGGGTTGCGCCCACGTGAATCTCAAGCCGATGCCATCTTTAA





2461
GGGCATGGTTGCCGACGTCAAGGGCAACCATCCTATTCCCATCTCCAACTTCATGAACGC





2521
ACAGTgtatgtgacgccactgtggtggcatggatggctcgtcctcaattcggagactgac





2581
actggagcaccctagACTTCTCCGAGATCACGATTGGAACACCCCCTCAGTCATTCAAGG





2641

TGGTCCTCGATACCGGTAGCTCCAACCTGTGGGTTCCATCAGTCGAGTGCGGCTCGATTG






2701
CTTGTTACCTGCACTCGAAGTATGACTCATCTGCCTCGTCCACCTACAAGAAGAACGGAA





2761
CCTCGTTCGAGATCCGCTACGGGTCAGGCAGCCTGAGCGGGTTTGTCTCTCAGGACACAG





2821
TGTCCATCGGCGATATCACTATCCAGGGCCAGGACTTTGCCGAGGCGACCAGCGAGCCCG





2881
GTCTTGCCTTTGCCTTTGGCCGTTTCGACGGTATCCTTGGCCTTGGCTACGACCGGATCT





2941
CAGTCAACGGCATCGTCCCGCCTTTTTACAAGATGGTCGAGCAGAAGCTCATCGATGAGC





3001
CCGTCTTCGCCTTCTACCTGGCCGATACCAATGGCCAGTCTGAGGTTGTCTTTGGCGGTG





3061
TTGACCACGACAAGTACAAGGGCAAGATCACCACCATTCCGTTGAGGCGCAAGGCCTACT





3121
GGGAGGTTGACTTCGATGCCATTTCTTACGGCGACGACACTGCCGAGCTTGAGAACACTG





3181
GCATCATCCTGGACACCGGTACTTCTCTGATCGCTCTGCCCAGCCAGCTCGCCGAGATGC





3241
TCAACGCTCAGATCGGCGCTAAGAAGAGCTACACTGGCCAGTACACCATCGACTGCAACA





3301
AGCGCGACTCCCTCAAGGATGTCACGTTCAACCTGGCTGGCTACAATTTCACGCTCGGCC





3361
CCTACGACTACGTTCTCGAGGTCCAGGGCAGCTGCATTTCTACCTTTATGGGCATGGATT





3421
TCCCGGCTCCTACTGGGCCACTTGCGATCCTGGGCGATGCCTTCCTCCGGAGGTATTACT





3481
CCATTTATGACCTTGGCGCCGACACCGTCGGTCTGGCTGAGGCCAAGtgattgaaggatg





3541
ggcggcagggaaagacgatgggtaatacggggagtctgggaatcgggctttggactgtgg





3601
tctgtatctagttgctcaagagagttgtcgtttgattttgttataggatctgtctaggaa





3661
ccttagcaggagtgaaattttttcgtgtacgagcatcggcgggctgaagtggtttgataa





3721
caagtctggacttgagtacgcaggcagttgcacaatctgcttcgccgaggagagcaaagg





3781
cgtcctctttgaaaaagcctacctacgcgtcacaggggtataattttttgagtttgacct





3841
acgccctgtcccataccaaccgcgtcccaatccccgtcaacccttgcaatgtcattaccc





3901
gtggatgtatcacgtagcagaagccgacatcccacacgcttcaaccttcctatccagaca





3961
atgacatggtaagctcattttttaaaggtcgccgtcctccctcccttcacgtgattcatt





4021
ttccttgcgccttgtggcgcatcccctgacttcatgccgtacggatcaaagggtgcaaac





4081
ttgccccgcacctcttttctgccgccatcatcatcaccatcatcgccgtttgtcgcctgc





4141
gcagcatgtagcacggacgacgccttgctgtagtcaaacggctcctgctcggcatcgtca





4201
tcatggccttcctcctgttcgcccgaggtctgttcgtcggctgccgaggtcgcggcggag





4261
gcagatgtctgctgctgctgctgctgctgctgcttctgggctttcttggcggctcgaagt





4321
gccttcctggcttgagccttgagttcctttgctccctttatgtctccgttttgagccagt





4381
tgctctgccaagagctgagcacgcttgaactcttctcgagcagccttcttggcttgtttc





4441
tttgcctgcttggcggccttgtcatcaccaccctcaacttcctgctcgacactaggagac





4501
ttcgggtggtctttgcctgcggaactatctccacccatctcgatgtcggaaactgcttcg





4561
gcttcggatgctgactcaacatcaacatccctagacttccgctttcgaccagccttcaga





4621
gtgaaaccttcttcttcgagaacagggagacccttggtgtcttgttcagcgacacgcctg











Pep4 amino acid sequence (SEQ ID No 20):










1
MKDAFLLTAA VLLGSAQGAV HKMKLQKIPL SEQLEAVPIN TQLEHLGQKY MGLRPRESQA






61
DAIFKGMVAD VKGNHPIPIS NFMNAQYFSE ITIGTPPQSF KVVLDTGSSN LWVPSVECGS





121
IACYLHSKYD SSASSTYKKN GTSFEIRYGS GSLSGFVSQD TVSIGDITIQ GQDFAEATSE





181
PGLAFAFGRF DGILGLGYDR ISVNGIVPPF YKMVEQKLID EPVFAFYLAD TNGQSEVVFG





241
GVDHDKYKGK MTTIPLRRKA YWEVDFDAIS YGDDTAELEN TGIILDTGTS LIALPSQLAE





301
MLNAQIGAKK SYTGQYTIDC NKRDSLKDVT FNLAGYNFTL GPYDYVLEVQ GSCISTFMGM





361
DFPAPTGPLA ILGDAFLRRY YSIYDLGADT VGLAEAK











his2a DNA sequence (SEQ ID No 21):










1
cattcatggg tttgaggccc gattttgaac gtatatccta ggctatattc ggggtaagat






61
actggaagcg ctgggccgga tgactagcta tttcaagtgc ccaagagccc atcataccta





121
acttgtggcc taagatctag ccaaatcatt cattggttac cccagactcg acgaacctga





181
tattcgaatc cagggcaagt caaatcgccg agtaagactt gacaaacccg gaacccaaga





241
actgcgcaat ctgggagcag gtttccgacc agcatggaaa caccccgatg gaaaacccac





301
acatacgggg atggggacta acgccggaca aatcaaaaac cctggaggat tgggtaacga





361
tggggaagtg cgacgggcac tcaacccttc aagcgttgca ggaccttgta cagccaagca





421
gaatgacgga aaccgatgag caaacccgga atctgatgat cctggaacag aatcatctgt





481
cttgggtacc gacgttggag tgagagtgtg caaattagca ggatcaagca actatactac





541
ctaaatcagg tcgatcagtt atcagccctt gcaaaccaga cttgatggag ggaagaggtg





601
aaagctgtga ttgagggagg aagctgagaa ttggtggtgg ttgttttgct cagccagggt





661
gtaggacgag aagaacgcgt tcgagatttc ggagagcagg ctgtcctaga gcattatttt





721
cctggccttg agcaaactta agccagtttt tttttccccg tcgggaggga agtcgctttg





781
aatttgaagc ttgcgggcgc agagctcggc tccataagca tccaatcaaa tgagcctgaa





841
gcagtcgacc gatttttttt tatctgggtg taatcgcaac catgcacata accgttttgg





901
gactagctcc aacagctccg atcaacaacc tgagaaaggc gcgagtgatc cgtgatccca





961
cacccttacg cgaaaactac ttaactccca cctcccccac cgcgggtcaa cttcttccaa





1021
ctcccactca accaacttcc gttttcccat caatcactgc attcgcgcgt caagctcttc





1081
ctcgccctta caccaaccac ataacttttt tatcctttga caaggaccat caatcaaaAT





1141
GACTGGCGGC GGCAAGTCCG GTGGCAAGGC GAGCGGTTCC AAGAACGCGC AATCgtaggt





1201
gcccttttcg cgtcatctac ccgcgccttc gtgcagttgg gcatggttca gccttgaact





1261
ccagatgccc gttccggtgc tcttacagtt ggctaacttt ttgtagTCGT TCATCTAAGG





1321
CCGGTCTTGC GTTCCCTGTC GGTCGTGTCC ACCGCCTTCT CCGGAAGGGC AACTACGCCC





1381
AGCGTGTCGG TGCCGGTGCT CCCGTTTACC TGGCTGCCGT TCTCGAGTAT CTTGCCGCTG





1441
AAATTCTGGA GCTGGCTGGC AACGCCGCTC GCGACAACAA GAAGACGCGT ATCATCCCGC





1501
GTCACTTGCA ACTCGCTATC AGGAACGATG AGGAGTTGAA CAAGCTTCTC GGGCACGTCA





1561
CCATCGCCCA GGGTGGTGTC CTTCCCAACA TCCACCAGAg tacgttgcct taccagacga





1621
tctctaatgc gcaaatctaa ctttgtttcc agACCTTCTG CCGAAGAAGA CCGGCAAGAC





1681
CGGCAAGAAC TTGTCGCAGG AGCTCtgatt ttcgcggttg ggtttttttg ctttattttc





1741
tggtcggcac gctgggttca tgatatcggg gtcacggttt cgggtcattg gttgcttttt





1801
gcgcgtgttt gggctgtaca ttaattccat gatgggcatg gtcatggtta tgaatgagaa





1861
tatcctctga acatccaaat cctgacacag tttgctcgag ttgatgtctg cattggaagc





1921
gactcgttga cggtaccgcg tagagtcttg tcgcttacga aattcttgca tcgcacagat





1981
tacccagtag tgccatagta ctctttaaga tgataagtgc atttgagccc ggcatcgcac





2041
agactttccc atgccttgat atatgcgaat tcctatgtac aagagattcg tcgcgaaaga





2101
gcccgtcaaa acttgagcgg ggggggagct gcaaaagcct gtcagctaat tcgagtgaga





2161
cgcgcaaagc aagccaactt acgatccagg tggggcgccg ggaggtttct ctcgtatttc











His2A amino acid sequence (SEQ ID No 22):













1
MTGGGKSGGK ASGSKNAQSR SSKAGLAFPV GRVHRLLRKG NYAQRVGAGA PVYLAAVLEY






61
LAAEILELAG NAARDNKKTR IIPRHLQLAI RNDEELNKLL GHVTIAQGGV LPNIHQNLLP





121
KKTGKTGKNL SQEL











hex1 DNA sequence (SEQ ID No 23):










1
gtcaacttactccgagtctcgcatcgagttcgatactgagcaccgtactcacaactccgt






61
cattgacgttgctgagggcgagtatcgtgcccgtgtccagcccaaccaccgcaagcaagc





121
ttccgtagtcggtaccaccgtcaacggatcgcggttcagccacagccgcaaggccagcag





181
caccacctccacccacaccgacgagtacaccgtcgatccccctagccaccgccccgtcta





241
caagaaggagtcggttgaagtcgccggtaccactgttgacccccctgctcctcgttcgac





301
ctaccacgagcaggtgaacattgttgaagagaccgttgacgctcaccgttacgctcctca





361
acccaacaacaacaacaagATGGGCTACTACGACGAGGACGgtaagcatcttccttcccc





421
tttgatgttgttccttacccgtgacatccatcggtcgtatgctttcttagccacacacaa





481
gtgttgtgacaagtgccgtgctcacgccgatatcagGCCACTACCACTCTTTCCGCCATG





541
GATTGCACAAGTTGGCTGACCGTATTGCGCATCCTGAAGGCCATGACCGCGTTGAGGTGA





601
GCGAGGTTCGTGAGACCCGCCGCACCCGCGCTCCGTCTTCGGAGGCGTACACGCCGAACA





661
CGGTCACCATTCCGTGCCACCACATCCGCCTCGGCGACATCCTGATCCTCCAGGGCCGCC





721
CCTGCCAGGTCATCCGTATCTCGACCTCGGCTGCCACTGGCCAGCACCGCTATCTTGGTG





781
TCGACCTCTTCACCAAGCAGCTCCATGAGGAGTCGTCGTTCGTCTCGAACCCTGCTCCCA





841
GCGTCGTCGTCCAGACGATGCTTGGCCCTGTTTTCAAGCAGTACCGCGTCCTCGACATGC





901
AGGACGGCCACATCGTCGCCATGACCGAGACGGGCGATGTCAAGCAGAACCTGCCCGTCA





961
TCGACCAGAGCAACCTCTGGGGCCGCCTCAAGCAGGCCTTCGAGACTGGCCGCGGCAGCG





1021
TCCGTGTCCTGGTCGTTTCTGACAACGGCAACGAGATGGCTGTTGACATGAAGGTCGTCC





1081
ACGGCTCGCGCCTCTAAgtcaagccggcaggctttcatgcaagctttggggctacgagtc





1141
gggcggcattgggtttgcgtttgatgcatcttggttacggcgtgtatgtcatttgaagat





1201
tgaaagctgcgccttggtcgactcctggcgccggatggatatacatgttcctcgggagga





1261
tatgaaggtttcatgtcgctagtttcacgtgtatatgatgactgtaatggatggatgttt





1321
atggccaactttgcgattgatatcttgaaccttttttctggtcgtgtgagtgaacagtga





1381
ttaagtgagagtgaggtatgcaccgtttatcacaaggttgccttgatatcccaccttcaa





1441
cgggcgtggggaatcgaagtccctcccctacagtaagtagcctctcttgaatgatctgaa





1501
acgcaacccctccgagccactaccacacctaactacgaaacaaccactttcctgttccag





1561
gaagctccagttctcccgctaccctcccctcccgccgttcaggttgtacgcttatctccc





1621
aacctcatcttcgagaggtctaatccgtacacacttaacagtgcatcctgacatagctaa





1681
ccatcatcactctagttcattagccgtcccgccatcccgtcaattacattcccggctgtt











Hex1 amino acid sequence (SEQ ID No 24):










1
MGYYDEDGHY HSFRHGLHKL ADRIAHPEGH DRVEVSEVRE TRRTRAPSSE AYTPNTVTIP






61
CHHIRLGDIL ILQGRPCQVI RISTSAATGQ HRYLGVDLFT KQLHEESSFV SNPAPSVVVQ





121
TMLGPVFKQY RVLDMQDGHI VAMTETGDVK QNLPVIDQSN LWGRLKQAFE TGRGSVRVLV





181
VSDNGNEMAV DMKVVHGSRL











bgl1: see WO 2009/018537. Note that bgl1 = Bgl3A.






xyl6: see WO 2009/018537.





cbhl: see WO 2009/018537. Note that cbh1 = CBHIa.





Pchi1(0.8) (SEQ I No 25):


AGCTTGACCCTTTCAGAGCTAGGTTTCATTAGGCCTTCGAAAACAACCCAAGGCCCCGTC





GCAACCATCACAACCGGCCGATAACCAGATCTCGGTAGGTCCGATAAGGATCCAAAATGG





TGTCGGCTGACGTTGCATGTGCCCAGGCAGGAGGATGATCCCCAGGGTTGTTGCCGGCAG





CTCCCGCACGTCGGGGAGGGGGAGGGGGAGGGGAAAGCCCTAACTAACGTTCGTTCTATC





ACGGGCCGACCGGGCCATGCTTTCGGCTTGTGAGCGGTGGGGTCAAGGGCAACAAGAAAT





GCTAAGTGCGGGACGAAGACACGCGGGCATGAGGTCTCAGGGTGACCTGCGCAAAACCAA





GTCCCACTCGCCATGCCTCCAGCAGCAACGTTGCCGTAGAAGGGTCAGGGGGTTTGTTGT





AGACCCACGACCATGCTGCCGGCGAGCGGAGGGTTGGCTTGCTACAGGCGCTGAAGGGTC





AACTCGGTGCCCAAAGTGGCTACCAAGCGTGCCATCAAGGGAAATGAGATGATGGTGGCT





CGTGGGCAAAGAAAAGACAAGGGAGGTGACTCTAGAGAGATGCTCTCGAGTTCACGGGTA





TAAGAGCACTGTGATCGTTCACAAAGCCGGCGTACTCCTCTAGAGCATCTATCATCAACA





TCACCAGAAAGGTCNTAGACCAGGTGGTTGCCATATCCAGTCGCAAAAGAGCCAAAGAGC





GAAGGAGCACGAAAGCACAGCCCAATCATTCCCTGCTTTGCTACTTCTTCTCCACCcustom character





Pchi1(1.8)(SEQ ID No 26):


GTCCCTTACCTATGGGCTCCTAGTCTCGTTCCTCTTTTTGATAGATTTGTATTTTGCAAC





GTTGCAAAATGAGACATTTCAATCATATGTAGCCGCCAGCTACTGTTAGCGTACTCAGCG





TTGCCCAAACGGCGGTTTTTCTGGGTAGCACTGTGCCGCGTGCCCCTGAGCCGTGCGTCG





CGGAAACCCCCTTAAGTAGCAAGTATGTTACCGCCGAGACCGACAATGCTGTTGGTTACC





TCGCTGGTCCATGATTGCAATCTAGATATCGTGCGGGGCTTTTGCAATCGGTTTTCCCTA





CCCACTTTCTTCTTTTGGACACTTTCTCTTTTGGAAAATGCCGAAATGATGCGGCTCGCT





CACGCCCCGAAGTCCCGAGCTGGGGCTAGATCCGTGATTGCAACGCGGTGCGAACGCGAC





TGGGGCAGACCTCGCTCAGCCTTGGTCGTGCCGGAATGGCGGGTACCTTTACCAGGTCGG





GATCAATTACATAGGATGCCATGTGCGTGGATTTGATTGCATCGCTGTCCCTTTTGTATG





TGTCCGAGAGCGAGACATCAACGCGAAAACCGGAATGCTCCCAACGTCGCTCTCTGTTCA





TAGGGTCTTTTTTTTTCTTCTGCTCCATATCATCTGTCTTGAACTAAGTGATCATCTGCT





GTCACGTCCCGCCCAATGATTGTAAAGAATGATAAGTGATGCTCGCCGGGGCCAGGCTCT





GTGAAAGTTCCCTCTTTGGTTGACGATCAGGTAGCGCCAACGTTGATTGGGCCGCCCGTA





AAATCCGACCCTGTCTCCTTTCGTTGCAAGTCTCCGCGAGACCGTGCCAAGCATGTTCTC





CGGATCCCTCAATTACATAAGGTTTGGCTCCAGGGTAGGTCTGGAAGCTACCCACCTCGG





CCAAGCAACCAATCACAACCAGACCTCGCGGCGTTTCGACCTTCCTGGTTTGTCTCAGGG





CTGGCCAACGTCCTCCCGTGGCGGGTGCCTGGTGATCGCAGGTCGCAGGCGAGTGCCGGG





CACGCGGAGCCCCCGTCAAAGCTTGACCCTTTCAGAGCTAGGTTTCATTAGGCCTTCGAA





AACAACCCAAGGCCCCGTCGCAACCATCACAACCGGCCGATAACCAGATCTCGGTAGGTC





CGATAAGGATCCAAAATGGTGTCGGCTGACGTTGCATGTGCCCAGGCAGGAGGATGATCC





CCAGGGTTGTTGCCGGCAGCTCCCGCACGTCGGGGAGGGGGAGGGGGAGGGGAAAGCCCT





AACTAACGTTCGTTCTATCACGGGCCGACCGGGCCATGCTTTCGGCTTGTGAGCGGTGGG





GTCAAGGGCAACAAGAAATGCTAAGTGCGGGACGAAGACACGCGGGCATGAGGTCTCAGG





GTGACCTGCGCAAAACCAAGTCCCACTCGCCATGCCTCCAGCAGCAACGTTGCCGTAGAA





GGGTCAGGGGGTTTGTTGTAGACCCACGACCATGCTGCCGGCGAGCGGAGGGTTGGCTTG





CTACAGGCGCTGAAGGGTCAACTCGGTGCCCAAAGTGGCTACCAAGCGTGCCATCAAGGG





AAATGAGATGATGGTGGCTCGTGGGCAAAGAAAAGACAAGGGAGGTGACTCTAGAGAGAT





GCTCTCGAGTTCACGGGTATAAGAGCACTGTGATCGTTCACAAAGCCGGCGTACTCCTCT





AGAGCATCTATCATCAACATCACCAGAAAGGTCNTAGACCAGGTGGTTGCCATATCCAGT





CGCAAAAGAGCCAAAGAGCGAAGGAGCACGAAAGCACAGCCCAATCATTCCCTGCTTTGC





TACTTCTTCTCCACCcustom character





Phex1 (SEQ ID No 27):


GATCCTAAGTAAGTAAACGAACCTCTCTGAAGGAGGTTCTGAGACACGCGCGATTCTTCT





GTATATAGTTTTATTTTTCACTCTGGAGTGCTTCGCTCCACCAGTACATAAACCTTTTTT





TTCACGTAACAAAATGGCTTCTTTTCAGACCATGTGAACCATCTTGATGCCTTGACCTCT





TCAGTTCTCACTTTAACGTANTTCGCGTTAGTCTGTATGTCCCAGTTGCATGTAGTTGAG





ATAAATACCCCTGGAAGTGGGTCTGGGCCTTTGTGGGACGGAGCCCTCTTTCTGTGGTCT





GGAGAGCCCGCTCTCTACCGCCTACCTTCTTACCACAGTACACTACTCACACATTGCTGA





ACTGACCCATCATACCGTACTTTATCCTGTTAATTCGTGGTGCTGTCGACTATTCTATTT





GCTCAAATGGAGAGCACATTCATCGGCGCAGGGATACACGGTTTATGGACCCCAAGAGTG





TAAGGACTATTATTAGTAATATTATATGCCTCTAGGCGCCTTAACTTCAACAGGCGAGCA





CTACTAATCAACTTTTGGTAGACCCAATTACAAACGACCATACGTGCCGGAAATTTTGGG





ATTCCGTCCGCTCTCCCCAACCAAGCTAGAAGAGGCAACGAACAGCCAATCCCGGTGCTA





ATTAAATTATATGGTTCATTTTTTTTAAAAAAATTTTTTCTTCCCATTTTCCTCTCGCTT





TTCTTTTTCGCATCGTAGTTGATCAAAGTCCAAGTCAAGCGAGCTATTTGTGCTATAGCT





CGGTGGCTATAATCAGTACAGCTTAGAGAGGCTGTAAAGGTATGATACCACAGCAGTATT





CGCGCTATAAGCGGCACTCCTAGACTAATTGTTACGGTCTACAGAAGTAGGTAATAAAAG





CGTTAATTGTTCTAAATACTAGAGGCACTTAGAGAAGCTATCTAAATATATATTGACCCT





AGCTTATTATCCCTATTAGTAAGTTAGTTAGCTCTAACCTATAGATAGATGCATGCGGCC





GCAGGTACCAGGCAATTCGCCCTATAGTGAGTCGTATTACGCGCGCTCACTGGCCGTCGT





TTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACA





TCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACA





GTTGCGCAGCCTGAATGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGG





TGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTT





CGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCG





GGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGA





TTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGAC





GTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTTCCAAACTGGAACAACACTCAACCC





TATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAA





AAATGAGCTGATTTAACAAAAATTTAACGCGAATTTTAACAAAATATTAACGCTTACAAT





TTAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATA





CATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGA





AAAAGGAAGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCA





TTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGAT





CAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAG





AGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTTTTAAAGTTCTGCTATGTGGC





GCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCT





CAGAATGACTTGGTTGAGTACTCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACA





GTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTT





CTGACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCAT





GTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCATACCAAACGACGAGCGT





GACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTA





CTTACTCTAGCTTCCCGGCAACAATTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGA





CCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGT





GAGCGTGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATC





GTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAAATAGACAGATCGCT





GAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATA





CTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGGATCTAGGTGAAGATCCTTTTT





GATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCC





GTAGAAAAGATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTG





CAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACT





CTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTG





TAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTG





CTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGAC





TCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACA





CAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGA





GAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTC





GGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATCTTTATAGTCCT





GTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGG





AGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCT





TTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCC





TTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGC





GAGGAAGCGGAAGAGCGCCCAATACGCAAACCGCCTCTCCCCGCGCGTTGGCCGATTCAT





TAATGCAGCTGGCACGACAGGTTTCCCGACTGGAAAGCGGGCAGTGAGCGCAACGCAATT





AATGTGAGTTAGCTCACTCATTAGGCACCCCAGGCTTTACACTTTATGCTTCCGGCTCGT





ATGTTGTGTGGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTATGACCATGAT





TACGCCAAGCGCGCAATTAACCCTCACTAAAGGGAACAAAAGCTGGAGCTCCACCGCGGT





GGCGGCCGCTCTAGAACTAGTACGGCGTGCAAGTAGTGTCTTTCTTTGCACTCCCGCCGT





CCCAGAAGACGCCGCAACAAGCTGAGCTTGCTGGAAGCCGAACAAAGGCGTTACAGAGCA





CAAACATAGTGGCAGTGTAGGAACTCTAACTGGGACCAAAACTACGGGCCCGGCAGAAAC





GTTCCCCGCCCCGAAGCGAAGGCGAACGTCGAAAAGCAAGACCGGGACCGCTCGTCCCAG





GATTAGCCACGAAGTTCCAGACCAAGTATAGGAGTAAACGCTCGCTCGTCAAAACAATTG





TCACCAATCAGCACCACATCGGCACATAACAACCGGTTGCGGAACTCGCATGTGAACAAC





AAGCGGCTCCGGGGGAGTGATCGGCTCGGGCGGATGACCCGGACTCTTCCGCGCAGCAAC





TCGGCGTGTTGTTGACGGCAGTACTCCGTAGTTGCCATGACAACAGTCAATGGCGTGCTT





CACAAGGTGGAGAGCCGAGAAAGCACCTCGGCATGTACGAGTATGTAGATAGTGTATCAA





GCAGGAAGATGGGGGTTACTTTATCTCAATCAGATGCCTGTAAGCGAGAGCCGAGAGCCT





GCCCTGTTGTTGACACAATTCTGGCCTGATACGAGTGACAAGCGCTGGGACGGCGGCTGG





GGTCTTTTGCTCGCGGCTTCAGCTCAATTCCAATCCTGGGCCGGTGCCGAACGGCCCAAT





CGCGAGCGCCCACGAAATCGGAGGTCGAGGAAAGAAGGCTGGGCGAGACGCGGCGACAAG





CTGTGGCAAAATGGCCAATTGAGGTTCTGGGTCGGCTGGTGATCAACCATGCATTTCCCA





GCCCGCAGATTCTCTTTCTCTCTCGTGCAGCAGCGGCACCAGCAGCAGCAGCAGCCAGGG





GTTTGACCAACCTCTCCGCCCAGCCACCGATAGTAAAGATGCTGCCTGCGTATTCTGGGC





TGCAGGAGTTCCAAGATCTTTCGGTCTGGCCACCAGCTGTCACGTCACCCTCCACCTTTG





GACGACGTTGCTGGAAAATTCGAAGCCTTCACTAAGATAACTATGCCGTAGCACTTGCAG





CCCCGGAAGCTGCAAGTTGATTCTTGGAGGGCTCTCTCCACCACCAATACGGGAGATCTG





GCCCCGCACTTGAGGAGGCTGGAGTCTCGGATCGCCCACTTCGCGTCGCCCTGGGCCCTG





GGCCCTGGGGTGATGGGCCCGTTGCCGTGGTGGATGGCAGGAGCTTTTCAGCTCTCAATG





GGCGAATGCTACTCCGTAGGTCGGAGTGGCTGGAAGCGGCGGAACGGACAGGGGGAGGTT





GGGGAAAATGCTCCGCAGGAAGAGCAGGGAGTGGGGAGCTGCGGTCGGCCCTGTGGAGCC





CGTGCAGGGCCAGCTAATCCAATTCGGGCCACAATAAACAAGAGAGGGCCCCACATCATG





TAAACAGAGGCTCAGAAGCTCCTGCCACACTGGGAGGGTTTCGAAGTCTGACGACTGCCA





ATGGACCCCAGCCATCGCGAGCACACAGCAGTTCGCACGCTCCCATTGGGTTCCTCATCA





CGCAGTCGCTCTCCCCGCCAACCAGCGCCAGGTCCGGGAACAGCGGCGCAAATGCGTATT





TGAGGGCGCCTCGCTCGAGCAACCTGTGCCTGACCTTCTCCTCCTCCTTCTGCACCTTGC





ATCTCGTCGCGTCCACTCGCAGGCAACCACACATCCTCCTCCTCTCCCAAAACCCCCCCG





CTTTTTCTTTCCCTTGTTGGAATTCGATTGAAAAAGAAGACGGGTCCGTCTAGAGACCGC





CTTCTCACCTTTCTCTCGACTTCTTTCTAGGAAAAGAAGCAAGAGTCATTCTTCTTGTCC





ACCTTCTGGTTCACGGAAGGTCGAGGAGAAGATTGCCTCTGCCCCCAAAGTCGCCAACCT





GGACTTTGAAGCACGTGTTCCGGTCCCTTTCAGTGTCTTCCCGTCCTCGTACAGGGAGTC





CGAGACCGCCACCCAAACCCACTCCCACGAAGAGGTTGAGATCAAGCTCCCCCAGCTCGC





CGGACGGGAAGGTCAACACTCTTCATTCCAAGCCCAAGCACATCTTCCTCCCAGCGGAGA





GGGTCGCTTCAGAGAAGAAGAGGTCCGCATCACTCGTCAAGAGGAACATCACCGCCGTCC





CGGCATCCGTGAAGAGTTCGTTCACCGCGAGGAGCGTCACCGGTAAGTTTAGTTTTTGTT





TTGATTCACCACCCATTGTCTTCCCCGCCTTTTTCTTTTTCTTCCCTTGCTCTCTTGCCC





CTGTCTAGTGTAGGGCATTGCCAAGGCCATCTTCACACACACACACCCCCCCCCCCCCCC





ACCCTCAGCTGGGGGGGGGGGTGGCCTGGGTTGACCAAGGGACGGTGAAGACTACTACTA





CTTGAGCCACTCAAACCCATGCATGACACAGGGTTTTCCTTTTTCTTTTCTCTTTTCCTT





TAACTAACCAACCACTCCAACATTAGCCCTCAGTCAACCTACTCCGAGTCTCGCATCGAG





TTCGATACTGAGCACCGCACTCACAACTCCGTCATTGACGTTGCTGAGAGCGAGTATCGT





GCCCGTGTCCAGCCCAACTACCGCAAGGAAGCTTCCGTAGTCGGTACCACCGTCGACGGA





TCCCGCTTCAGCCACAGCCGCAAGGCCAGCAGCACCACCTCCACCCACACCGACGAGTAC





ACCGTCGATCCCCCTAGCCACCGCCCCGTCTACAAGAAGGAGTCGGTTGAAGTCGCCGGT





ACCACTGTTGACCCCCCTGCTCCTCGTTCGACCTACCACGAGCAGGTGAACATTGTTGAA





GAGACCGTTGACGCTCACCGTTACGCTCCTCAACCCAACAACAACAACACCcustom character





Pxyl6 (SEQ ID No 28):


GCGGCCGCTTCCCCATGAATGGCAACCGGGCTGATGACCTGTGTGGGAAGAAATGGGGTT





GGGTCGGGCAATGGGAAGAAAACGGAAAGAGGGAAGGAAACATGCCTGTAGTCGAGGCTG





AGAGTGTACGTACGTCCGTACATTCCAGTAACCAGGCGAGAATGAGCAATGATACCCCGC





ATTTCTTGGATAATTAACTCGTTCCAGAGCACGACTTACGCAGCACTACTCCGTACTGTT





GGAGCGCTTAGCACGCTGGAAACTTGGCAGCCGTCCGAAGCCGCTCGGCCCCATCCTCTC





GCTGGTAGCTAGTGTAGTCCCGTGCTTTACAACGCGGCTATACAGCCCGTACAGTTGTAA





AGTACCTACATACATGCACTACTATTATTATCCTTCTAGAGTGGGTTCCGAATTCCAGGG





AAGATCTTCCTATGGCTATCTGGCTGAAACTTGGGGGAGGAGTGCGGAAGGGGGGAGGGG





AACGAGCCTCCACATTGCATACGACCGGGGAATGCGGGACCCTAAGCGAACCAGGAACCC





GGTTATTGCACTCGGAATTGCCGCAGATCCCTGCGTTCCACCCGCTCGAACGGTCAACAT





TAACTAATCTGTAGTGGAGTTACTGTTGACTTTCTGACTCGTGTCACTGGTCCTCGCCCA





AGTTCGAAAACAGAATTGCATTTTTGTCCTTTTGTTCGGAGCTTTCGAGGAATAATTCCA





TTGTAGGTATGGAGTAATTATGGAGTATACACGGCCCAGGGGCGCTACACACACCATCGC





CGAGAATGGGAGGTCGAGCTCGCGACGCTCAGGATCCCATCGATATTTTCCCTTATCCCT





GCTCTCACTAGCGCGCAGAGCCGCCTCCGCGCGGGGATGCCGGTTGTTGCCGGCGTGCTT





TTTATCCGCTGCCCTTGGTTGCTCATTTCCCGGTTCTTGGGTCGCTTGCCAAGCAGCTCC





GGCGGAGAAGAATACCACAGGAGGGAGCATCGGGGCGCGAAGGGCATTGCACTATGCGGA





CGAGATGCTTCAACACCATCATGGACCTGTCCGGAACTCCCAAGAACAGGCGACGCCAAG





GACGGAGTAGACCTCCCCGGTCCGTCTTCTCTCTGCCTGGCAATTTAGCCAAAAATCCGA





CCCGACTTGCGACGATTCCTACCTCCTAGCGCGTGCGCGCTGAAGCAGTCGCGAGAGTCG





CAAGGCATGGGCCCGAGTCTGGCTGGCATCGTCAAACGTGATCGGCCCGTCGAGCGTGCG





TGTATAAATGCATCAAGGAGCGACTGCCCCCCCATCAATAACCACCCGGTTGCTTGAGTC





TCTCGCACTCGCGGCCCCTTCTTCTCTGCTTCGCACGCATCTCGCTGTCTCGCTGTCTCG





CTGTCTCACTGTCTCGCTGTCTCACTGTCTCGCTGTCTCACTGTCTCGCTGTCTCACTGT





CTCACTCGTCCATCAGAGCAAAACCcustom character





Pgla1 (SEQ ID No 29):


TAGTAGTTGTCAACCTTGGCAGCGAGAGTCCCGAGGCGGTAGATGAGAGAAAAAAGGACC





GATGTTGACTTCCATGCCATCGATGGCGTCGTCTCGGCTAGACGTCGTCGGCGTTATTCT





GGGGGAGGCAATCCCGGGTGAGGAGAGAAATAGACGCGTCGCCATCTAGCAGCCATCACT





CAGTGGCATCACCTGCGCGTTGACTTGCCTTCGAAGGCTCTCCTGAGCCGAGCATGTGAT





TACGATGTATAAGACCTGCATTGAGCTCGACGTTCCCGAGCGTCGGCGCGAGCTTCCAAT





TCGGTTGAGGCTCCGGCGGCTTCCCCCGGTTTCCTGCTGGACTAGCTGCCGTGGCGGGGG





GACGGCAGAGCGACTCCGACGCGCCCCATGCGAGCAACGGCCCGATTTTCGATGAGATCT





GCGGGGCGCCGGAGTGGCAGCAGTTCGTCAGCTTGGCAGGCACGGCTCCCCACCTTCTTC





CTTCTTCCACACTAGGCCCTCCCACAAGCGACCAGATGCTTGTTAAGTACGCAGTAGTGT





CTCGGCTCGCCCAGAGAACAATGGCACGCCGATCTGTCTAATGACCAAGAGCCACGGTTC





GAGACCATCCATTGGACTGGAGGGCCTGCGAGGCATCACGCCGAACCCATGTCATGCTAC





TCTTTCTGTTCACCCCCGGAGATGGCGTGAAACTGCGCGTTTACTCGCGGCTCAGCATGT





GCTCACGTTGGGTAGGTCCCGCAAAGTCAGAGGTAGGGAGGTACTTTGTAGGCACAAATC





ATGTACACGTTCGTACCTGAGGTAGCTATCTCGCCTCAGGCACACGAGGCCCGTTCGACG





AGAGAGAGGAAGAGCAACCAAGAATAGTCAAGGATATTATTACTCTTTCCCTGGTATTTC





TGGACATTTTGTCCAGGATTTTGTTCGCCCTTTAATTTTGAACAATTATGCTCCCGTCGG





CTCCGATCCACGCCTCTTAACTCTCCTTTAGCCTTTCGCCTCTATTTCCTTGAATTTCAA





TTCTCCCAAGGGCCCTGCTTTCTACAGCAAAGAATCCGTACCCTACTCTCTTTCGCGCAC





AGAGTGAGGGAGCAACAGGGATTGCGAAATGCACAGCAGAGTTTGTGTAACTTCGGCAGC





TCTTCCCCACATTCAGATGCATGTTACTGGAGAATGCGGAGAAGTTATAGTCTGGGGTAG





TAGGTATAACGCTGGTACTCCCGAGGTAGGTAGCAACCTTGGCTGACCTTGGGAAGCGAG





GGCGCTTGTGACGCTGACGATCCAGAAGCAGCCCGCCGATAGTATACGTGGAGACGGTGC





TTCTTGCTATAAGCGCTCAACTCCGCTACCCATGTTCACCGTCTTCCCCTTGGACGACGG





CATCACTCCGATACCCATGTCTCCTGGGTAGCTCCGAGTAGTCGCCCGAGCGCCCTTCTC





CCCCCTCCCCCTTTCTCCTAATAAACGGCCGAGTCGGGCAGCCTCGACGTTGCACCGTAG





CGTCGCAGCCTGCGTAGAAGCACGCGTAGAAGCACCGAGCTCCAAGCTCCAAGACGCCAA





AAGCCGCCGCGAAGTGGCCGTCGGCCCTTCCCCGCATGCGCAGCTCCGGCACCAGGTCCG





AAACGCTCCATCACCCCATATCCCAGTCAGAACAGCGGCTGCTTTCCGGATTTGGAAGTC





TGGAGGTCGCGAATGAAGGCTCGCGTTCGACTATAATAACAGCTCCGGATGGCAGGCCTC





GTTGCCCAGCTCCAGGACCACCTCCCATCCGTAAACGGATCTGGCCTCGTCACGCCCGCC






custom character






Alp1 DNA sequence comprises (SEQ ID No 30):


ATGCACTTCTCCACCGCTCTCCTGGCCTTCCTGCCCGCCGCCCTCGCGGCCCCTACTGCCGAGACCCTCGAC





AAGCGCGCCCCGATCCTGACTGCTCGCGCTGGCCAGGTCGTCCCGGGCAAGTACATCATCAAGCTCCGCGAC





GGAGCCAGCGACGATGTCCTTGAGGCCGCCATCGGCAAGCTCCGCTCCAAGGCCGACCACGTCTACCGCGGC





AAGTTCAGGGGCTTTGCCGGCAAGCTCGAGGATGACGTCCTTGACGCCATCCGTCTTCTCCCCGAAgtgagt





ccgcgtcccggaaagaaatagagcgagcgggggagagagtgaagggcgaaaagagccgtgttttgttaaccg





cttgtcttttctttctctcttgcaatagGTCGAGTACGTCGAGGAGGAGGCCATCTTCACCATCAACGCGTA





CACCTCGCAGTCCAACGCCCCCTGGGGCCTTGCGCGCCTCTCGTCCAAGACCGCGGGCTCCACCACCTACAC





CTACGACACCAGCGCCGGCGAGGGCACCTGTGCCTATGTGATCGACACGGGCATCTACACTAGCCACTCCgt





atgtctcgcggttacctcccctttcggaagaaggggcatccatatgctgacccctcctgatcacagGACTTC





GGCGGCCGTGCCACTTTCGCCGCCAACTTCGTCGACAGCTCTAACACCGATGGCAACGGCCACGGCACCCAC





GTCGCCGGCACCATCGGCGGCACCACGTACGGTGTTGCCAAGAAGACCAAGCTCTACGCCGTCAAGGTTCTC





GGCTCCGACGGCTCTGGCACCACgtatgcctcgcacccgcgcacccgcacacccgcccggccgttatcttct





gactgacattcctctttctcctctctagTTCTGGTGTCATTGCTGGCATCAACTTCGTCGCTGACGACGCGC





CCAAGCGCAGCTGCCCCAAGGGCGTCGTCGCCAACATGTCGCTCGGCGGTAGCTACTCGGCCTCCATCAACA





ACGCCGCCGCCGCCCTCGTCAGGTCGGGCGTCTTCCTGGCCGTCGCCGCCGGCAACGAGAACCAGAACGCCG





CCAACTCGTCGCCCGCCTCCGAGGCGTCCGCCTGCACCGTCGGCGCCACCGACAGGAACGACGCCAAGGCCA





GCTACTCCAACTACGGCAGCGTCGTCGATATCCAGGCCCCCGGCTCCAACATCCTGAGCACCTGGATCGGCA





GCACCTCTGCTACCgtaagccccccctccccccacccacccccagcctttggcgacattcccgccccgtatt





tatttctccggggtgggggagaaacaaaacaaaatagctaacatgagatgcactctcagAACACCATCTCGG





GTACCTCGATGGCCTCCCCCCACATTGCCGGCCTCGGTGCCTACCTCCTGGCCCTCGAGGGCTCCAAGACCC





CTGCCGAGCTCTGCAACTACATCAAGTCGACCGGCAACGCCGCCATCACTGGCGTTCCCAGCGGCACCACCA





ACCGCATCGCCTTCAACGGCAACCCCTCTGCCtga





Alp1 amino acid sequence (SEQ ID No 31):









1
MHFSTALLAF LPAALAAPTA ETLDKRAPIL TARAGQVVPG KYIIKLRDGA SDDVLEAAIG






61
KLRSKADHVY RGKFRGFAGK LEDDVLDAIR LLPEVEYVEE EAIFTINAYT SQSNAPWGLA





121
RLSSKTAGST TYTYDTSAGE GTCAYVIDTG IYTSHSDFGG RATFAANFVD SSNTDGNGHG





181
THVAGTIGGT TYGVAKKTKL YAVKVLGSDG SGTTSGVIAG INFVADDAPK RSCPKGVVAN





241
MSLGGSYSAS INNAAAALVR SGVFLAVAAG NENQNAANSS PASEASACTV GATDRNDAKA





301
SYSNYGSVVD IQAPGSNILS TWIGSTSATN TISGTSMASP HIAGLGAYLL ALEGSKTPAE





361
LCNYIKSTGN AAITGVPSGT TNRIAFNGNP SA






LIST OF REFERENCES



  • Braaksma, M. and P. J. Punt. 2008. Aspergillus as a cell factory for protein production: controlling protease activity in fungal production, p. 441-455. In G. H. Goldman and S. A. Osmani (ed.), The Aspergilli: Genomics, Medical Aspects, Biotechnology, and Research Methods, CRC Press, Boca Raton.

  • Verdoes, J. C., Punt, P. J., Burlingame, R., Bartels, J., van Dijk, R., Slump, E., Meens, M., Joosten, R. and Emalfarb, M., 2007. A dedicated vector for efficient library construction and high throughput screening in the hyphal fungus Chrysosporium lucknowense. Industrial Biotechnology 3, 48-57.


Claims
  • 1. A strain of Chrysosporium lucknowense selected from the group consisting of W1L deposited at CBS under accession number 122189, W1L#100.1 deposited at CBS under accession number 122190, and a strain derived therefrom by gene disruption.
  • 2. The strain of claim 1 in which the gene encoding endochitinase 1 (chi1) has been disrupted.
  • 3. The strain of claim 1 in which one or more genes encoding alkaline protease 1 (alp1), alkaline protease 2 (alp2), proteinase A (pep4), glucoamylase (Gla1), exochitinase (Chi2) or laminarinase (Lam1) has been disrupted.
  • 4. The strain of claim 1, selected from the group consisting of: (a) W1L#100.1Δalp1Δpyr5, and(b) W1L#100.1Δalp1Δchi1Δpyr5.
  • 5. A method for producing a homologous or heterologous protein comprising expressing a gene encoding said homologous or heterologous protein in the Chrysosporium lucknowense strain of claim 1.
  • 6. The method of claim 5, wherein said homologous or heterologous protein is produced with a purity of higher than 75%.
  • 7. A method for producing a protein mixture comprising homologous and/or heterologous proteins, which method comprises expressing genes encoding said proteins of said mixture in the Chrysosporium lucknowense strain of claim 1.
  • 8. A method for isolating a genetically modified fungal strain of Chrysosporium lucknowense strain UV 18-25, wherein cellulase and protease secretion is less than 20% of endogenous cellulase and protease secretion of unmodified Chrysosporium lucknowense strain UV 18-25, comprising the steps of: (i) mutagenizing fungi of said Chrysosporium lucknowense strain UV 18-25,(ii) plating the mutagenized fungi on ASC plates,(iii) selecting at least one colony showing a reduced cellulose clearing zone, enhanced sporulation and white color,(iv) plating the at least one colony selected in step (iii) on skim milk plates, and(v) selecting from the plates of step (iv) at least one colony showing a reduced protein degradation halo,
  • 9. The method of claim 8, further comprising a step of mutagenizing the fungi prior to step (iv).
  • 10. A method for isolating a genetically modified fungal strain of Chrysosporium lucknowense strain UV 18-25, wherein cellulase secretion is less than 20% of endogenous cellulase secretion of unmodified Chrysosporium lucknowense strain UV 18-25, comprising the steps of: (i) mutagenizing fungi of said Chrysosporium lucknowense strain UV 18-25;(ii) plating the mutagenized fungi on ASC plates; and(iii) selecting a colony showing a reduced cellulose clearing zone, enhanced sporulation and white color from the plates of step (ii), thereby isolating said modified fungal strain.
Priority Claims (1)
Number Date Country Kind
09003750 Mar 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/NL2010/000045 3/16/2010 WO 00 12/5/2011
Publishing Document Publishing Date Country Kind
WO2010/107303 9/23/2010 WO A
US Referenced Citations (3)
Number Name Date Kind
6573086 Emalfarb et al. Jun 2003 B1
20070173431 Day et al. Jul 2007 A1
20080194005 Emalfarb et al. Aug 2008 A1
Foreign Referenced Citations (10)
Number Date Country
1237207 Dec 1999 CN
1330717 Jan 2002 CN
1380905 Nov 2002 CN
WO 9815633 Apr 1998 WO
WO 0020555 Apr 2000 WO
WO 0179507 Oct 2001 WO
WO 2005001036 Jan 2005 WO
WO 2008073914 Jun 2008 WO
WO 2009018537 Feb 2009 WO
WO 2009033071 Mar 2009 WO
Non-Patent Literature Citations (11)
Entry
Search Report issued in connection with Application No. 201080020447.5, dated Aug. 31, 2012 (in Chinese).
English translation of Office Action issued in connection with Application No. 201080020447.5, dated Aug. 31, 2012.
Braaksma et al, “Aspergillus as a Cell Factory for Protein Production: Controlling Protease Activity in Fungal Production”, The Aspergilli: Genomics, Medical Aspects, Biotechnology, and Research Methods CRC Press, Boca Raton, 441-455 (2008).
Verdoes et al, “A dedicated vector for efficient library construction and high throughput screening in the hyphal fungus Chrysosporium lucknowense”, Industrial Biotechnology 3, 48-57 (2007).
Visser et al, “Chrysosporium lucknowense is a versatile fungal host for gene discovery and protein production”, Abstracts, J. of Biotechnology, S211-S241 (2007).
Lever, “A New Reaction for Colorimetric Determination of Carbohydrates”, Analytical Biochemistry 47, 273-279 (1972).
Punt et al, “Fungal Protein Production: Design and Production of Chimeric Proteins”, Annu. Rev. Microbiol. 2011, 65:57-69.
International Search Report for PCT/NL2010/000045, mailed Oct. 26, 2010.
Hinz, Sandra W.A. et al., “Hemicellulase Production in Chrysosporium Lucknowense C1”, Journal of Cereal Science, vol. 50, No. 3, (Nov. 2009), pp. 318-323.
Hallemeersch, I. et al., “Regulation of Cellulase and Hemicellulase Synthesis in the Fungus Chrysosporium SP”, Communications in Agricultural and Applied Biological Sciences, vol. 68, No. 2, (Jan. 1, 2008), pp. 301-304.
Verdoes, Jan C. et al., “Original Research: A Dedicated Vector for Efficient Library Construction and High Throughput Screening in the Hyphal Fungus Chrysosporium Lucknowense”, Industrial Biotechnology, vol. 3, No. 1, (Jan. 1, 2007), pp. 48-57.
Related Publications (1)
Number Date Country
20120107856 A1 May 2012 US